{
    "id": "dbpedia_6522_0",
    "rank": 55,
    "data": {
        "url": "https://elifesciences.org/articles/54712",
        "read_more_link": "",
        "language": "en",
        "title": "Agonist-mediated switching of ion selectivity in TPC2 differentially promotes lysosomal function",
        "top_image": "https://elifesciences.org/assets/images/social/icon-600x600@1.52e87ee6.png",
        "meta_img": "https://elifesciences.org/assets/images/social/icon-600x600@1.52e87ee6.png",
        "images": [
            "https://elifesciences.org/assets/patterns/img/patterns/organisms/elife-logo-xs@1x.f9b97bde.png",
            "https://elifesciences.org/assets/patterns/img/icons/corresponding-author@1x.075234c5.png",
            "https://elifesciences.org/assets/patterns/img/icons/corresponding-author@1x.075234c5.png",
            "https://elifesciences.org/assets/patterns/img/icons/corresponding-author@1x.075234c5.png",
            "https://elifesciences.org/assets/patterns/img/icons/corresponding-author@1x.075234c5.png",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig1-v4.tif/full/617,/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig2-v4.tif/full/617,/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig3-v4.tif/full/617,/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig4-v4.tif/full/617,/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-video1.jpg/full/639,/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-video2.jpg/full/639,/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig5-v4.tif/full/617,/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig6-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig7-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig8-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig9-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig10-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig11-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig12-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig13-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig14-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig15-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig16-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig17-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig18-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig19-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig20-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig21-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig22-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig23-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig24-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig25-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig26-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig27-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig28-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig29-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig30-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig31-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig32-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig33-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig34-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig35-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig36-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig37-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig38-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig39-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig40-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig41-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig42-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig43-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig44-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig45-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig46-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig47-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig48-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig49-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig50-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig51-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig52-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig53-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig54-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig55-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig56-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig57-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig58-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig59-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig60-v4.tif/full/617,/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig61-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig62-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig63-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig64-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig65-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig66-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig67-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig68-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig69-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig70-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig71-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig72-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig73-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig74-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig75-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig76-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig77-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig78-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig79-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig80-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig81-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig82-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig83-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig84-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig85-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig86-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig87-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig88-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig89-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig90-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig91-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig92-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig93-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig94-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig95-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig96-v4.tif/full/full/0/default.jpg",
            "https://iiif.elifesciences.org/lax/54712%2Felife-54712-fig97-v4.tif/full/full/0/default.jpg",
            "https://elifesciences.org/assets/patterns/img/icons/orcid.e0a7f9de.png",
            "https://elifesciences.org/assets/patterns/img/icons/orcid.e0a7f9de.png",
            "https://elifesciences.org/assets/patterns/img/icons/orcid.e0a7f9de.png",
            "https://elifesciences.org/assets/patterns/img/icons/orcid.e0a7f9de.png",
            "https://elifesciences.org/assets/patterns/img/icons/orcid.e0a7f9de.png",
            "https://elifesciences.org/assets/patterns/img/icons/orcid.e0a7f9de.png",
            "https://elifesciences.org/assets/patterns/img/icons/orcid.e0a7f9de.png",
            "https://elifesciences.org/assets/patterns/img/patterns/organisms/elife-logo-xs@1x.f9b97bde.png",
            "https://elifesciences.org/assets/images/investors/hhmi@1x.739f96c8.png",
            "https://elifesciences.org/assets/images/investors/wellcome@1x.b38198be.png",
            "https://elifesciences.org/assets/images/investors/max@1x.71f18cc3.png",
            "https://elifesciences.org/assets/images/investors/kaw@1x.d11d4f95.png",
            "https://elifesciences.org/assets/patterns/img/patterns/molecules/carbon-neutral.706efe6d.svg"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [
            "Susanne Gerndt",
            "Cheng-Chang Chen",
            "Yu-Kai Chao",
            "Yu Yuan",
            "Sandra Burgstaller",
            "Anna Scotto Rosato",
            "Einar Krogsaeter",
            "Nicole Urban",
            "Katharina Jacob",
            "Ong Nam Phuong Nguyen"
        ],
        "publish_date": "2020-03-13T00:00:00",
        "summary": "",
        "meta_description": "The lysosomal ion channel TPC2 emerges as an example of an ion channel in which ion selectivity is not fixed but rather agonist-selective.",
        "meta_lang": "en",
        "meta_favicon": "/assets/favicons/apple-touch-icon-57x57.c2b7763c.png",
        "meta_site_name": "eLife",
        "canonical_link": "https://elifesciences.org/articles/54712",
        "text": "Chemical structure 1\n\nAccording to general procedure A, 4-(trifluoromethyl)aniline (812 µL, 6.47 mmol, 1.1 eq.), 2-cyanoacetic acid (500 mg, 5.88 mmol, 1.0 eq.) and DCC (1.27 g, 6.17 mmol, 1.1 eq.) in DMF (7.0 mL) were used to yield amide SGA-34 as colorless crystals (983 mg, 4.31 mmol, 73%). Analytical data are in accordance with literature (Davies et al., 2009; Sjogren et al., 1991). Rf = 0.14 (4:1 hexanes/acetone). m.p.: 195°C [(Sjogren et al., 1991): 191–193°C]. 1H NMR (400 MHz, (CD3)2SO) δ/ppm = 10.65 (s, 1H, NH), 7.75 (d, J = 8.8 Hz, 2H, 3’-H, 5’-H), 7.70 (d, J = 8.8 Hz, 2H, 2’-H, 6’-H), 3.95 (s, 2H, 2 hr). 13C NMR (101 MHz, (CD3)2SO) δ/ppm = 161.9 (C-1), 141.9 (C-1’), 126.3 (q, JCF = 3.7 Hz, C-3’, C-5’), 124.4 (q, JCF = 271.4 Hz, CF3), 124.0 (q, JCF = 32.0 Hz, C-4’), 119.2 (C-2’, C-6’), 115.7 (CN), 27.0 (C-2). IR (ATR) V~max/cm−1=3287, 3221, 3147, 1681, 1612, 1557, 1319, 1110, 1065, 849, 835. HRMS (ESI): calcd. for C10H6F3N2O (M-H)- 227.04377; found 227.04371. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 2\n\nAccording to general procedure A, p-toluidine (712 µL, 6.47 mmol, 1.1 eq.), 2-cyanoacetic acid (500 mg, 5.88 mmol, 1.0 eq.) and DCC (1.27 g, 6.17 mmol, 1.1 eq.) in DMF (7.0 mL) were used to yield amide one as colorless crystals (728 mg, 4.18 mmol, 71%). Analytical data are in accordance with literature (Yuan et al., 2019). Rf = 0.14 (4:1 hexanes/acetone). m.p.: 184°C [(Yuan et al., 2019): 186°C]. 1H NMR (400 MHz, (CD3)2SO) δ/ppm = 10.19 (s, 1H, NH), 7.47–7.36 (m, 2H, 2’-H, 6’-H), 7.13 (d, J = 8.2 Hz, 2H, 3’-H, 5’-H), 3.86 (s, 2H, 2 hr), 2.25 (s, 3H, CH3). 13C NMR (101 MHz, (CD3)2SO) δ/ppm = 160.7 (CO), 135.9 (C-1’), 132.9 (C-4’), 129.3 (C-3’, C-5’), 119.2 (C-2’, C-6’), 116.0 (CN), 26.6 (C-2), 20.4 (CH3). IR (ATR) V~max/cm−1=3267, 3207, 3137, 1660, 1613, 1552, 1510, 819. HRMS (ESI): calcd. for C10H9N2O (M-H)- 173.07204; found 173.07194. Purity (HPLC): >96% (λ = 210 nm), >96% (λ = 254 nm).\n\nChemical structure 3\n\nAccording to general procedure A, aniline (1.96 mL, 21.5 mmol, 1.0 eq.), 2-cyanoacetic acid (2.01 g, 23.6 mmol, 1.1 eq.) and DCC (4.87 g, 23.6 mmol, 1.1 eq.) in DMF (20 mL) were used to yield amide two as colorless crystals (2.60 g, 16.2 mmol, 76%). Analytical data are in accordance with literature (Yuan et al., 2019). Rf = 0.12 (4:1 hexanes/acetone). m.p.: 202°C [(Yuan et al., 2019): 172°C]. 1H NMR (500 MHz, (CD3)2SO) δ/ppm = 10.28 (s, 1H, NH), 7.54 (dt, J = 8.7, 1.6 Hz, 2H, 2’-H, 6’-H), 7.39–7.29 (m, 2H, 3’-H, 5’-H), 7.15–7.04 (m, 1H, 4’-H), 3.89 (s, 2H, 2 hr). 13C NMR (126 MHz, (CD3)2SO) δ/ppm = 161.0 (CO), 138.4 (C-1’), 128.9 (C-3’, C-5’), 123.9 (C-4’), 119.2 (C-2’, C-6’), 115.9 (CN), 26.7 (C-2). IR (ATR) V~max/cm−1=3265, 3207, 3143, 3099, 3052, 1653, 1620, 1557, 1299, 943, 761, 696. HRMS (ESI): calcd. for C9H7N2O (M-H)- 159.05639; found 159.05628. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 4\n\nAccording to general procedure A, p-anisidine (2.36 mL, 20.3 mmol, 1.0 eq.), 2-cyanoacetic acid (19.0 g, 22.3 mmol, 1.1 eq.) and DCC (4.61 g, 22.3 mmol, 1.1 eq.) in DMF (20 mL) were used to yield amide three as pale blue crystals (1.58 g, 8.31 mmol, 41%). Analytical data are in accordance with literature (Yuan et al., 2019). Rf = 0.10 (4:1 hexanes/acetone). m.p.: 137°C [(Yuan et al., 2019): 176°C]. 1H NMR (400 MHz, (CD3)2SO) δ/ppm = 10.14 (s, 1H, NH), 7.53–7.38 (m, 2H, 2’-H, 6’-H), 7.00–6.83 (m, 2H, 3’-H, 5’-H), 3.84 (s, 2H, 2 hr), 3.72 (s, 3H, OCH3). 13C NMR (101 MHz, (CD3)2SO) δ/ppm = 160.4 (CO), 155.6 (C-4’), 131.4 (C-1’), 120.8 (C-2’, C-6’), 116.0 (CN), 114.0 (C-3’, C-5’), 55.2 (OCH3), 26.5 (C-2). IR (ATR) V~max/cm−1=3299.3150, 1655, 1608, 1557, 1511, 1251, 1032, 828. HRMS (ESI): calcd. for C10H9N2O2 (M-H)- 189.06695; found 189.06688. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 5\n\nAccording to general procedure A, 4-chloroaniline (682 µL, 23.0 mmol, 1.0 eq.), 2-cyanoacetic acid (2.16 g, 25.4 mmol, 1.1 eq.) and DCC (5.23 g, 25.4 mmol, 1.1 eq.) in DMF (20 mL) were used to yield amide four as colorless crystals (3.46 g, 17.8 mmol, 77%). Analytical data are in accordance with literature (Yuan et al., 2019). Rf = 0.14 (3:2 hexanes/acetone). m.p.: 207°C [(Yuan et al., 2019): 179°C]. 1H NMR (500 MHz, (CD3)2SO) δ/ppm = 10.42 (s, 1H, NH), 7.62–7.51 (m, 2H, 2’-H, 6’-H), 7.50–7.27 (m, 2H, 3’-H, 5’-H), 3.91 (s, 2H, 2 hr). 13C NMR (126 MHz, (CD3)2SO) δ/ppm = 161.2 (CO), 137.3 (C-1’), 128.8 (C-3’, C-5’), 127.5 (C-4’), 120.8 (C-2’, C-6’), 115.8 (CN), 26.8 (C-2). IR (ATR) V~max/cm−1=3264, 3200, 3132, 3083, 1664, 1610, 1548, 1491, 832. HRMS (ESI): calcd. for C9H635ClN2O (M-H)- 193.01741; found 193.01750. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 6\n\nAccording to general procedure A, 4-bromoaniline (2.00 mL, 17.1 mmol, 1.0 eq.), 2-cyanoacetic acid (1.60 g, 18.8 mmol, 1.1 eq.) and DCC (3.88 g, 18.8 mmol, 1.1 eq.) in DMF (20 mL) were used to yield amide five as colorless crystals (1.62 g, 6.76 mmol, 40%). Analytical data are in accordance with literature (Yuan et al., 2019). Rf = 0.14 (4:1 hexanes/acetone). m.p.: 186°C [(Yuan et al., 2019): 185°C]. 1H NMR (400 MHz, (CD3)2SO) δ/ppm = 10.42 (s, 1H, NH), 7.52 (s, 4H, 2’-H, 3’-H, 5’-H, 6’-H), 3.90 (s, 2H, 2 hr).13C NMR (101 MHz, (CD3)2SO) δ/ppm = 161.2 (CO), 137.7 (C-1‘), 131.7 (C-2‘, C-6’ or C-3’, C-5’), 121.2 (C-2‘, C-6’ or C-3’, C-5’), 115.8 (C-4’), 115.5 (CN), 26.8 (C-2). IR (ATR) V~max/cm−1=3322, 2927, 2849, 1608, 1547, 1245, 828. HRMS (ESI): calcd. for C9H679BrN2O (M-H)- 236.96690; found 236.96692. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 7\n\nAccording to general procedure A, 4-fluoroaniline (2.16 mL, 22.5 mmol, 1.0 eq.), 2-cyanoacetic acid (1.91 g, 22.5 mmol, 1.0 eq.) and DCC (4.64 g, 22.5 mmol, 1.0 eq.) in DMF (20 mL) were used to yield amide six as colorless crystals (3.00 g, 16.9 mmol, 75%). Analytical data are in accordance with literature (Ammar et al., 2006). Rf = 0.11 (4:1 hexanes/acetone). m.p.: 179°C [(Ammar et al., 2006): 158–160°C]. 1H NMR (400 MHz, (CD3)2SO) δ/ppm = 10.34 (s, 1H, NH), 7.66–7.46 (m, 2H, 2’-H, 6’-H), 7.27–7.09 (m, 2H, 3’-H, 5’-H), 3.89 (s, 2H, 2 hr). 13C NMR (101 MHz, (CD3)2SO) δ/ppm = 161.0 (CO), 158.3 (d, JCF = 240.5 Hz, C-4’), 134.7 (d, JCF = 2.7 Hz, C-1’), 121.1 (d, JCF = 7.9 Hz, C-2’, C-6’), 115.9 (CN), 115.5 (d, JCF = 22.3 Hz, C-3’, C-5’), 26.6 (C-2). IR (ATR) V~max/cm−1=3274, 3166, 3107, 1662, 1623, 1566, 1505, 834. HRMS (ESI): calcd. for C9H6FN2O (M-H)- 177.04696; found 177.04687. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 8\n\nAccording to general procedure A, 4-iodoaniline (4.50 g, 20.5 mmol, 1.0 eq.), 2-cyanoacetic acid (17.5 g, 20.5 mmol, 1.0 eq.) and DCC (4.24 g, 20.5 mmol, 1.0 eq.) in DMF (20 mL) were used to yield amide seven as pale blue crystals (4.50 g, 15.7 mmol, 77%). The compound is literature known, but no analytical data are available (Sjogren et al., 1991). Rf = 0.11 (4:1 hexanes/acetone). m.p.: 218°C. 1H NMR (400 MHz, (CD3)2SO) δ/ppm = 10.38 (s, 1H, NH), 7.78–7.60 (m, 2H, 3’-H, 5’-H), 7.49–7.29 (m, 2H, 2’-H, 6’-H), 3.90 (s, 2H, 2 hr). 13C NMR (101 MHz, (CD3)2SO) δ/ppm = 161.2 (CO), 138.2 (C-1’), 137.6 (C-3’, C-5’), 121.4 (C-2’, C-6’), 115.8 (CN), 87.6 (C-4’), 26.8 (C-2). IR (ATR) V~max/cm−1=3265, 3188, 3113, 3078, 1666, 1543, 1391, 1299, 823. HRMS (ESI): calcd. for C9H6IN2O (M-H)- 284.95303; found 284.95302. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 9\n\nAccording to general procedure A, 4-nitroaniline (696 µL, 7.24 mmol, 1.0 eq.), 2-cyanoacetic acid (616 mg, 7.24 mmol, 1.0 eq.) and DCC (1.49 g, 7.24 mmol, 1.0 eq.) in DMF (20 mL) were used to yield amide eight as yellow solid (918 mg, 4.47 mmol, 62%). Analytical data are in accordance with literature (Sohn et al., 2017). Rf = 0.11 (4:1 hexanes/acetone). m.p.: 218°C [(Sohn et al., 2017): 220°C]. 1H NMR (400 MHz, (CD3)2SO) δ/ppm = 10.88 (s, 1H, NH), 8.35–8.15 (m, 2H, 3’-H, 5’-H), 7.93–7.71 (m, 2H, 2’-H, 6’-H), 4.00 (s, 2H, 2 hr). 13C NMR (101 MHz, (CD3)2SO) δ/ppm = 162.2 (CO), 144.4 (C-1’), 142.7 (C-4’), 125.1 (C-3’, C-5’), 119.0 (C-2’, C-6’), 115.5 (CN), 27.2 (C-2). IR (ATR) V~max/cm−1=3287, 1673, 1562, 1503, 1336, 1259, 860, 748. HRMS (ESI): calcd. for C9H6N3O3 (M-H)- 204.04146; found 204.04146. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 10\n\nAccording to general procedure A, 4-aminobenzonitrile (1.00 g, 8.46 mmol, 1.0 eq.), 2-cyanoacetic acid (7.20 g, 8.46 mmol, 1.0 eq.) and DCC (1.75 g, 8.46 mmol, 1.0 eq.) in DMF (10 mL) were used to yield amide nine as yellow solid (1.22 g, 6.57 mmol, 78%). The compound is literature known, but no analytical data are available (Sjogren et al., 1991). Rf = 0.08 (4:1 hexanes/acetone). m.p.: 201°C. 1H NMR (500 MHz, (CD3)2SO) δ/ppm = 10.72 (s, 1H, NH), 7.82–7.78 (m, 2H, 3’-H, 5’-H), 7.74–7.70 (m, 2H, 2’-H, 6’-H), 3.97 (s, 2H, 2 hr). 13C NMR (126 MHz, (CD3)2SO) δ/ppm = 162.0 (CO), 142.5 (C-1’), 133.5 (C-3’, C-5’), 119.3 (C-2’, C-6’), 118.9 (C-4’), 115.6 (CH2CN), 105.7 (CN), 27.1 (C-2). IR (ATR) V~max/cm−1=3268, 3194, 3118, 2229, 1599, 1538, 1504, 845. HRMS (ESI): calcd. for C10H6N3O (M-H)- 184.05164; found 184.05161. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 11\n\nAccording to general procedure A, 4-aminoacetophenone (1.30 mL, 7.40 mmol, 1.0 eq.), 2-cyanoacetic acid (629 mg, 7.40 mmol, 1.0 eq.) and DCC (1.53 g, 7.40 mmol, 1.0 eq.) in DMF (10 mL) were used to yield amide 10 as yellow crystals (802 mg, 3.97 mmol, 54%). Analytical data are in accordance with literature (Metwally et al., 2017). Rf = 0.37 (3:2 hexanes/acetone). m.p.: 194°C [(Metwally et al., 2017): 225°C]. 1H NMR (500 MHz, (CD3)2SO) δ/ppm = 10.63 (s, 1H, NH), 7.99–7.91 (m, 2H, 3’-H, 5’-H), 7.74–7.62 (m, 2H, 2’-H, 6’-H), 3.96 (s, 2H, 2 hr), 2.53 (s, 3H, CH3). 13C NMR (101 MHz, (CD3)2SO) δ/ppm = 196.5 (COCH3), 161.7 (HNCO), 142.6 (C-1‘), 132.2 (C-4‘), 129.6 (C-3‘, C-5‘), 118.5 (C-2‘, C-6‘), 115.7 (CN), 27.0 (C-2), 26.5 (CH3). IR (ATR) V~max/cm−1=3286, 2250, 1695, 1651, 1599, 1536, 1279, 1249, 833, 720. HRMS (ESI): calcd. for C11H9N2O2 (M-H)- 201.06695; found 201.06694. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 12\n\nAccording to general procedure A, 4-propoxyaniline (679 µL, 4.49 mmol, 1.0 eq.), 2-cyanoacetic acid (382 mg, 4.49 mmol, 1.0 eq.) and DCC (927 mg, 4.49 mmol, 1.0 eq.) in DMF (2.0 mL) were used to yield amide 11 as colorless crystals (604 mg, 2.77 mmol, 62%). Rf = 0.24 (95:5 CH2Cl2/EtOH). m.p.: 183°C. 1H NMR (400 MHz, (CD3)2SO) δ/ppm = 10.13 (s, 1H, NH), 7.51–7.38 (m, 2H, 2’-H, 6’-H), 6.98–6.83 (m, 2H, 3’-H, 5’-H), 3.88 (t, J = 7.1 Hz, 2H, CH2CH2CH3), 3.84 (s, 2H, 2 hr), 1.70 (sext, J = 7.1 Hz, 2H, CH2CH2CH3), 0.96 (t, J = 7.1 Hz, 3H, CH2CH2CH3). 13C NMR (101 MHz, (CD3)2SO) δ/ppm = 160.4 (CO), 155.1 (C-4’), 131.4 (C-1’), 120.8 (C-2’, C-6’), 116.0 (CN), 114.5 (C-3’, C-5’), 69.0 (CH2CH2CH3), 26.5 (C-2), 22.0 (CH2CH2CH3), 10.4 (CH2CH2CH3). IR (ATR) V~max/cm−1=3283, 3096, 1607, 1559, 1508, 1239, 828, 570. HRMS (ESI): calcd. for C12H13N2O2 (M-H)- 217.09825; found 217.09832. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 13\n\nAccording to general procedure A, 4-(trifluoromethoxy)aniline (939 µL, 7.00 mmol, 1.0 eq.), 2-cyanoacetic acid (595 mg, 7.00 mmol, 1.0 eq.) and DCC (1.44 g, 7.00 mmol, 1.0 eq.) in DMF (10 mL) were used to yield amide 12 as colorless solid (1.23 g, 5.03 mmol, 72%). The compound is literature known, but no analytical data are available (Sjogren et al., 1991). Rf = 0.39 (95:5 CH2Cl2/EtOH). m.p.: 154°C. 1H NMR (400 MHz, (CD3)2SO) δ/ppm = 10.49 (s, 1H, NH), 7.74–7.55 (m, 2H, 2’-H, 6’-H), 7.47–7.26 (m, 2H (3’-H, 5’-H), 3.92 (s, 2H, 2 hr). 13C NMR (101 MHz, (CD3)2SO) δ/ppm = 161.3 (CO), 144.0 (C-4‘), 137.5 (C-1‘), 121.8 (C-3’, C-5’), 120.7 (C-2’, C-6’), 120.1 (q, JCF = 255.7 Hz, OCF3), 115.8 (CN), 26.8 (C-2). IR (ATR) V~max/cm−1=3278, 2975, 1667, 1616, 1557, 1508, 1277, 1205, 1171. HRMS (ESI): calcd. for C10H6F3N2O2 (M-H)- 243.03869; found 243.03869. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 14\n\nAccording to general procedure A, methyl 4-aminobenzoate (3.00 g, 19.5 mmol, 1.0 eq.), 2-cyanoacetic acid (1.66 g, 19.5 mmol, 1.0 eq.) and DCC (4.01 g, 19.5 mmol, 1.0 eq.) in DMF (15 mL) were used to yield amide 13 as colorless solid (2.76 g, 12.6 mmol, 65%). The compound is literature known, but no analytical data are available (Sjogren et al., 1991). Rf = 0.44 (3:2 hexanes/acetone). m.p.: 162°C. 1H NMR (500 MHz, (CD3)2SO) δ/ppm = 10.63 (s, 1H, NH), 8.01–7.87 (m, 2H, 2 hr, 6 hr), 7.76–7.61 (m, 2H, 3 hr, 5 hr), 3.96 (s, 2H, 2 hr), 3.82 (s, 3H, CH3). 13C NMR (126 MHz, (CD3)2SO) δ/ppm = 165.7 (COOCH3), 161.7 (HNCO), 142.7 (C-4), 130.4 (C-2, C-6), 124.6 (C-1), 118.6 (C-3, C-5), 115.7 (CN), 52.0 (CH3), 27.0 (C-2). IR (ATR) V~max/cm−1=2809, 1722, 1608, 1558, 1507, 1431, 1274, 1110, 757. HRMS (ESI): calcd. for C11H9N2O3 (M-H)- 217.06187; found 217.06187. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 15\n\nAccording to general procedure A, 2-bromo-4-chloroaniline (1.00 g, 4.84 mmol, 1.0 eq.), 2-cyanoacetic acid (412 mg, 4.84 mmol, 1.0 eq.) and DCC (999 mg, 4.84 mmol, 1.0 eq.) in DMF (10 mL) were used to yield amide 14 as colorless crystals (919 mg, 3.36 mmol, 69%). Rf = 0.22 (3:2 hexanes/acetone). m.p.: 157°C. 1H NMR (400 MHz, (CD3)2SO) δ/ppm = 9.97 (s, 1H, NH), 7.83 (d, J = 2.4 Hz, 1H, 3’-H), 7.63 (d, J = 8.7 Hz, 1H, 6’-H), 7.49 (dd, J = 8.7, 2.4 Hz, 1H, 5’-H), 3.98 (s, 2H, 2 hr). 13C NMR (101 MHz, (CD3)2SO) δ/ppm = 161.8 (CO), 134.7 (C-1’), 132.0 (C-3’), 130.7 (C-4’), 128.2 (C-5’), 128.0 (C-6’), 118.5 (C-2’), 115.7 (CN), 26.1 (C-2). IR (ATR) V~max/cm−1=3281, 2258, 1666, 1577, 1530, 1470, 1284, 822. HRMS (ESI): calcd. for C9H579Br35ClN2O (M-H)- 270.92793; found 270.92809. Purity (HPLC): >93% (λ = 210 nm), >93% (λ = 254 nm).\n\nChemical structure 16\n\nAccording to general procedure A, 2-iodoaniline (1.00 g, 4.57 mmol, 1.0 eq.), 2-cyanoacetic acid (388 mg, 4.57 mmol, 1.0 eq.) and DCC (942 mg, 4.57 mmol, 1.0 eq.) in DMF (10 mL) were used to yield amide 15 as brown crystals (913 g, 3.19 mmol, 70%). Rf = 0.16 (4:1 hexanes/acetone). m.p.: 161°C. 1H NMR (400 MHz, (CD3)2SO) δ/ppm = 9.88 (s, 1H, NH), 7.90 (d, J = 7.6 Hz, 1H, 3’-H), 7.46–7.38 (m, 2H, 5’-H, 6’-H), 7.03 (ddd, J = 8.6, 5.4, 3.6 Hz, 1H, 4’-H), 3.93 (s, 2H, 2 hr). 13C NMR (101 MHz, (CD3)2SO) δ/ppm = 161.4 (CO), 139.1 (C-3’), 138.7 (C-1’), 128.8 (C-5’), 128.3 (C-4’), 127.4 (C-6’), 115.8 (CN), 96.4 (C-2’), 26.0 (C-2). IR (ATR) V~max/cm−1=3252, 2263, 1658, 1577, 1542, 1433, 1015, 758, 768. HRMS (ESI): calcd. for C9H6IN2O (M-H)- 284.95303; found 284.95295. Purity (HPLC): >96% (λ = 210 nm), >96% (λ = 254 nm).\n\nChemical structure 17\n\nAccording to general procedure A, 3-chloro-2,4-difluoroaniline (1.06 g, 6.48 mmol, 1.0 eq.), 2-cyanoacetic acid (551 mg, 6.48 mmol, 1.0 eq.) and DCC (1.34 g, 6.48 mmol, 1.0 eq.) in DMF (10 mL) were used to yield amide 16 as colorless crystals (1.01 g, 4.39 mmol, 68%). Rf = 0.16 (4:1 hexanes/acetone). m.p.: 144°C. 1H NMR (400 MHz, (CD3)2SO) δ/ppm = 10.32 (s, 1H, NH), 7.79 (td, J = 9.0, 5.8 Hz, 1H, 6’-H), 7.33 (td, J = 9.0, 2.1 Hz, 1H, 5’-H), 3.99 (s, 2H, 2 hr). 13C NMR (101 MHz, (CD3)2SO) δ/ppm = 162.0 (CO), 154.8 (dd, JCF = 246.5, 2.0 Hz, C-2’ or C-4’), 150.4 (dd, JCF = 250.4, 3.3 Hz, C-2’ or C-4’), 123.4 (dd, JCF = 8.8, 2.4 Hz, C-6’), 123.0 (dd, JCF = 11.8, 3.5 Hz, C-1’), 115.7 (CN), 111.9 (dd, JCF = 21.4, 3.8 Hz, C-5’), 108.7 (dd, JCF = 21.9, 19.7 Hz, C-3’), 26.3 (C-2). IR (ATR) V~max/cm−1=3274.2935, 2264, 1681, 1551, 1488, 1443, 1012, 831, 628. HRMS (ESI): calcd. for C9H435ClF2N2O (M-H)- 228.99857; found 228.99850. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 18\n\nAccording to general procedure A, 3,4-dimethoxyaniline (1.00 g, 6.53 mmol, 1.0 eq.), 2-cyanoacetic acid (555 mg, 6.53 mmol, 1.0 eq.) and DCC (1.35 g, 6.53 mmol, 1.0 eq.) in DMF (10 mL) were used to yield amide 17 as violet crystals (1.10 g, 4.99 mmol, 76%). The compound is literature known, but no analytical data are available (Edraki et al., 2016). Rf = 0.05 (4:1 hexanes/acetone). m.p.: 174°C. 1H NMR (500 MHz, (CD3)2SO) δ/ppm = 10.15 (s, 1H, NH), 7.21 (d, J = 2.4 Hz, 1H, 2’-H), 7.04 (dd, J = 8.7, 2.4 Hz, 1H, 6’-H), 6.90 (d, J = 8.7 Hz, 1H, 5’-H), 3.84 (s, 2H, 2 hr), 3.79–3.66 (m, 6H, 2x OCH3). 13C NMR (126 MHz, (CD3)2SO) δ/ppm = 160.5 (CO), 148.6 (C-3’), 145.3 (C-4’), 131.9 (C-1’), 116.0 (CN), 112.0 (C-5’), 111.2 (C-6’), 104.3 (C-2’), 55.7 (OCH3), 55.4 (OCH3), 26.6 (C-2). IR (ATR) V~max/cm−1=3273, 2914, 2256, 1660, 1513, 1239, 1132, 1020, 837. HRMS (ESI): calcd. for C11H11N2O3 (M-H)- 219.07752; found 219.07751. Purity (HPLC): >96% (λ = 210 nm), >96% (λ = 254 nm).\n\nChemical structure 19\n\nAccording to general procedure A, 2,3-dichloroaniline (745 µL, 6.30 mmol, 1.0 eq.), 2-cyanoacetic acid (536 mg, 6.30 mmol, 1.0 eq.) and DCC (1.30 g, 6.30 mmol, 1.0 eq.) in DMF (10 mL) were used to yield amide 18 as colorless crystals (414 mg, 1.81 mmol, 29%). Rf = 0.21 (4:1 hexanes/acetone). m.p.: 176°C. 1H NMR (500 MHz, (CD3)2SO) δ/ppm = 10.11 (s, 1H, NH), 7.69 (dd, J = 8.1, 1.3 Hz, 1H, 4’-H or 6’-H), 7.51 (dd, J = 8.1, 1.3 Hz, 1H, 4’-H or 6’-H), 7.38 (t, J = 8.1 Hz, 1H, 5’-H), 4.02 (s, 2H, 2 hr). 13C NMR (126 MHz, (CD3)2SO) δ/ppm = 161.9 (CO), 136.1 (C-1’ or C-3’), 132.0 (C-1’ or C-3’), 128.2 (C-5’), 127.3 (C-4’ or C-6’), 125.3 (C-2’), 124.8 (C-4’ or C-6’), 115.7 (CN), 26.3 (C-2). IR (ATR) V~max/cm−1=3287, 2253, 1666, 1580, 1527, 1415, 1338, 1182, 953, 788. HRMS (ESI): calcd. for C9H535Cl2N2O (M-H)- 226.97844; found 226.97859. Purity (HPLC): >96% (λ = 210 nm), >96% (λ = 254 nm).\n\nChemical structure 20\n\nAccording to general procedure A, 2,6-dibromoaniline (1.00 g, 4.00 mmol, 1.0 eq.), 2-cyanoacetic acid (340 mg, 4.00 mmol, 1.0 eq.) and DCC (825 mg, 4.00 mmol, 1.0 eq.) in DMF (10 mL) were used to yield amide 19 as colorless crystals (514 mg, 1.62 mmol, 40%). Rf = 0.48 (3:2 hexanes/acetone). m.p.: 187°C. 1H NMR (500 MHz, (CD3)2SO) δ/ppm = 10.37 (s, 1H, NH), 7.74 (d, J = 8.1 Hz, 2H, 3’-H, 5’-H), 7.22 (t, J = 8.1 Hz, 1H, 4’-H), 3.93 (s, 2H, 2 hr). 13C NMR (126 MHz, (CD3)2SO) δ/ppm = 161.1 (CO), 134.7 (C-1‘), 132.4 (C-3‘, C-5‘), 130.7 (C-4‘), 123.9 (C-2‘, C-6‘), 115.6 (CN), 25.4 (C-2). IR (ATR) V~max/cm−1=3326, 2926, 2851, 1626, 1568, 1539, 1242, 642. HRMS (ESI): calcd. for C9H579Br2N2O (M-H)- 314.87741; found 314.87761. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 21\n\nAccording to general procedure A, 3,5-bis(trifluoromethyl)aniline (1.09 mL, 7.00 mmol, 1.0 eq.), 2-cyanoacetic acid (595 mg, 7.00 mmol, 1.0 eq.) and DCC (1.44 g, 7.00 mmol, 1.0 eq.) in DMF (10 mL) were used to yield amide 20 as colorless crystals (1.68 g, 5.67 mmol, 81%). The compound is literature known, but no analytical data are available (Shah et al., 2018). Rf = 0.43 (95:5 CH2Cl2/EtOH). m.p.: 141°C. 1H NMR (500 MHz, (CD3)2SO) δ/ppm = 10.96 (s, 1H, NH), 8.28–8.12 (m, 2H, 2’-H, 6’-H), 7.90–7.77 (m, 1H, 4’-H), 4.00 (s, 2H, 2 hr). 13C NMR (126 MHz, (CD3)2SO) δ/ppm = 162.4 (CO), 140.2 (C-1’), 130.9 (q, JCF = 32.9 Hz, C-3’, C-5’), 123.1 (q, JCF = 272.7 Hz, CF3), 119.2–118.7 (m, C-2’, C-6’), 116.9–116.5 (m, C-4’), 115.4 (CN), 27.1 (C-2). IR (ATR) V~max/cm−1=3313, 1695, 1572, 1471, 1381, 1272, 1132, 889, 703, 681. HRMS (ESI): calcd. for C11H5F6N2O (M-H)- 295.03116; found 295.03127. Purity (HPLC): >96% (λ = 210 nm), >96% (λ = 254 nm).\n\nChemical structure 22\n\nAccording to general procedure A, N-methyl-4-(trifluoromethyl)aniline (403 µL, 2.85 mmol, 1.0 eq.), 2-cyanoacetic acid (243 mg, 2.85 mmol, 1.0 eq.) and DCC (589 mg, 2.85 mmol, 1.0 eq.) in DMF (10 mL) were used to yield amide 21 as colorless solid (513 mg, 2.12 mmol, 74%). Analytical data are in accordance with literature (Kobayashi and Harayama, 2009). Rf = 0.58 (95:5 CH2Cl2/EtOH). m.p.: 70°C [(Kobayashi and Harayama, 2009): 66–68°C]. 1H NMR (400 MHz, (CD3)2SO) δ/ppm = 7.77 (d, J = 8.6 Hz, 2H, 3’-H, 5’-H), 7.40 (d, J = 8.2 Hz, 2H, 2’-H, 6’-H), 3.34 (s, 3H, CH3), 3.23 (s, 2H, 2 hr). 13C NMR (101 MHz, (CD3)2SO) δ/ppm = 161.4 (CO), 145.6 (C-1’), 131.7 (C-4’), 127.9 (C-2’, C-6’ or C-3’, C-5’), 127.8 (C-2’, C-6’ or C-3’, C-5’), 123.5 (q, J = 271.4 Hz, CF3), 113.7 (CN), 38.1 (CH3), 25.6 (C-2). IR (ATR) V~max/cm−1=3152, 2355, 1657, 1611, 1322, 1122, 1103, 1065, 848. HRMS (ESI): calcd. for C11H8F3N2O (M-H)- 241.05942; found 241.05939. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 23\n\nAccording to general procedure A, 4-(trifluoromethyl)benzylamine (2.50 mL, 17.5 mmol, 1.0 eq.), 2-cyanoacetic acid (1.49 g, 17.5 mmol, 1.0 eq.) and DCC (3.62 g, 17.5 mmol, 1.0 eq.) in DMF (15 mL) were used to yield amide 22 as colorless solid (299 mg, 1.23 mmol, 7%). Analytical data are in accordance with literature (Guo et al., 2011). Rf = 0.46 (3:2 hexanes/acetone). m.p.: 113°C [(Guo et al., 2011): 128°C]. 1H NMR (500 MHz, (CD3)2SO) δ/ppm = 8.83 (t, J = 5.7 Hz, 1H, NH), 7.74–7.66 (m, 2H, 3’-H, 5’-H), 7.54–7.44 (m, 2H, 2’-H, 6’-H), 4.38 (d, J = 5.7 Hz, 2H, CH2), 3.73 (s, 2H, 2 hr). 13C NMR (126 MHz, (CD3)2SO) δ/ppm = 162.5 (CO), 143.6 (C-1’), 128.0 (C-2’, C-6’), 127.7 (q, JCF = 31.7 Hz, C-4’), 125.2 (q, JCF = 3.7 Hz, C-3’, C-5’). 124.3 (q, JCF = 272.1 Hz, CF3), 116.1 (CN), 42.2 (CH2), 25.3 (C-2). IR (ATR) V~max/cm−1=3316, 2937, 2364, 1734, 1664, 1547, 1325, 1152, 1107, 1066. HRMS (ESI): calcd. for C11H8F3N2O (M-H)- 241.05942; found 241.05949. Purity (HPLC): >96% (λ = 210 nm), >96% (λ = 254 nm).\n\nChemical structure 24\n\nAccording to general procedure B, amide SGA-34 (228 mg, 1.00 mmol, 1.0 eq.) in dry THF (10 mL), NaH (92.0 mg, 2.30 mmol, 2.3 eq.) and 3,5-dichlorobenzoyl chloride (230 mg, 1.10 mmol, 1.1 eq.) were used to yield TPC2-A1-N as colorless crystals (276 mg, 0.688 mmol, 69%). Rf = 0.62 (4:1 hexanes/acetone). m.p.: 202°C [(Sjogren et al., 1991): 208–210°C]. 1H NMR (500 MHz, (CD3)2SO) δ/ppm = 12.36 (s, 1H, NH), 7.79–7.76 (m, 2H, 2’-H, 6’-H), 7.65 (t, J = 1.9 Hz, 1H, 4’’-H), 7.62–7.60 (m, 2H, 3’-H, 5’-H), 7.59 (d, J = 1.9 Hz, 2H, 2’’-H, 6’’-H). 13C NMR (126 MHz, (CD3)2SO) δ/ppm = 182.7 (C-3), 166.5 (C-1), 144.9 (C-1’’), 143.6 (C-1’), 133.5 (C-3’’, C-5’’), 128.6 (C-4’’), 126.2–125.9 (m, C-3’, C-5’ and C-2’’, C-6’’), 124.6 (q, JCF = 286.1 Hz, CF3), 123.3 (C-2), 121.8 (q, JCF = 31.8 Hz, C-4’), 118.7 (C-2’, C-6’), 77.7 (CN). IR (ATR) V~max/cm−1=3293, 2213, 1538, 1409, 1320, 1268, 1244, 1167, 1106, 1070, 837, 810, 660, 591. HRMS (ESI): calcd. for C17H835Cl2F3N2O2 (M-H)- 398.99204; found 398.99202. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 25\n\nAccording to general procedure B, amide SGA-34 (228 mg, 1.00 mmol, 1.0 eq.) in dry THF (10 mL), NaH (92.0 mg, 2.30 mmol, 2.3 eq.) and benzoyl chloride (128 µL, 1.10 mmol, 1.1 eq.) were used to give SGA-10 as colorless crystals (185 mg, 0.557 mmol, 56%). Analytical data are in accordance with literature (Davies et al., 2009). Rf = 0.28 (3:2 hexanes/acetone). m.p.: 242°C [(Davies et al., 2009): 245–247°C]. 1H NMR (400 MHz, (CD3)2SO) δ/ppm = 12.12 (s, 1H, NH), 7.84–7.74 (m, 2H, 2’-H, 6’-H), 7.70–7.58 (m, 4H, 3’-H, 5’-H, Ph), 7.48–7.39 (m, 3H, Ph). 13C NMR (101 MHz, (CD3)2SO) δ/ppm = 185.7 (C-3), 167.3 (C-1), 143.1 (C-1‘), 139.7 (qPh), 135.0 (C-2), 130.0 (Ph), 127.8 (Ph), 127.6 (Ph), 126.0 (q, JCF = 3.8 Hz, C-3’, C-5’), 125.0 (d, JCF = 270.6 Hz, CF3), 122.3 (d, JCF = 35.2 Hz, C-4’), 119.4 (C-2’, C-6’), 77.8 (CN). IR (ATR) V~max/cm−1=3283, 2216, 1592, 1550, 1309, 1109, 1067, 840, 694. HRMS (ESI): calcd. for C17H10F3N2O2 (M-H)- 331.06999; found 331.06985. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 26\n\nAccording to general procedure B, amide SGA-34 (228 mg, 1.00 mmol, 1.0 eq.) in dry THF (10 mL), NaH (92.0 mg, 2.30 mmol, 2.3 eq.) and 3,5-dinitrobenzoyl chloride (254 mg, 1.10 mmol, 1.1 eq.) were used to give SGA-11 as red crystals (124 mg, 0.294 mmol, 29%). Rf = 0.21 (3:2 hexanes/acetone). m.p.: 240°C. 1H NMR (500 MHz, (CD3)2SO) δ/ppm = 12.32 (s, 1H, NH), 10.00 (s, 1H, OH), 8.89–8.80 (m, 3H, 2’’-H, 4’’-H, 6’’-H), 7.84–7.75 (m, 2H, 2’-H, 6’-H), 7.67–7.58 (m, 2H, 3’-H, 5’-H). 13C NMR (126 MHz, (CD3)2SO) δ/ppm = 180.5 (C-3), 166.1 (C-1), 147.6 (C-3‘‘, C-5‘‘), 144.4 (C-1’’), 143.5 (C-1‘), 127.6 (C-2‘‘, C-6‘‘),126.1 (q, JCF = 3.5 Hz, C-3‘, C-5‘),124.2 (q, JCF = 271.0 Hz, CF3), 123.3 (C-2), 121.8 (q, JCF = 31.7 Hz, C-4’), 119.0 (C-4’’), 118.6 (C-2’, C-6’), 77.7 (CN). IR (ATR) V~max/cm−1=3262, 3093, 2223, 1539, 1342, 1317, 1115, 1067, 841, 730, 703, 687. HRMS (ESI): calcd. for C17H8F3N4O6 (M-H)- 421.04014; found 421.04021. Purity (HPLC):>96% (λ = 210 nm), >96% (λ = 254 nm).\n\nChemical structure 27\n\nAccording to general procedure B, amide SGA-34 (228 mg, 1.00 mmol, 1.0 eq.) in dry THF (10 mL), NaH (92.0 mg, 2.30 mmol, 2.3 eq.) and 4-nitrobenzoyl chloride (204 mg, 1.10 mmol, 1.1 eq.) were used to give SGA-15 as yellow crystals (276 mg, 0.688 mmol, 69%). Rf = 0.19 (3:2 hexanes/acetone). m.p.: 217°C [(Sjogren et al., 1991): 211–214°C]. 1H NMR (500 MHz, (CD3)2SO) δ/ppm = 12.39 (s, 1H, NH), 8.28–8.19 (m, 2H, 3’’-H, 5’’-H), 7.84–7.80 (m, 2H, 2’’-H, 6’’-H), 7.78 (d, J = 8.6 Hz, 2H, 2’-H, 6’-H), 7.60 (d, J = 8.6 Hz, 2H, 3’’-H, 5’’-H). 13C NMR (126 MHz, (CD3)2SO) δ/ppm = 184.3 (C-3), 166.4 (C-1), 148.1 (C-1’’), 147.5 (C-4’’), 143.7 (C-1’), 128.6 (C-2’’, C-6’’), 126.1 (q, JCF = 3.6 Hz, C-3’, C-5’), 124.6 (q, JCF = 270.9 Hz, CF3), 123.2 (C-2), 123.1 (C-3’’, C-5’’), 121.6 (q, JCF = 32.0 Hz, C-4’), 118.6 (C-2’, C-6’), 77.9 (CN). IR (ATR) V~max/cm−1=3307, 2219, 1551, 1320, 1111, 1069, 844, 750, 700. HRMS (ESI): calcd. for C17H9F3N3O4 (M-H)- 376.05506; found 376.05509. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 28\n\nAccording to general procedure B, amide SGA-34 (228 mg, 1.00 mmol, 1.0 eq.) in dry THF (10 mL), NaH (92.0 mg, 2.30 mmol, 2.3 eq.) and 4-chlorobenzoyl chloride (141 µL, 1.10 mmol, 1.1 eq.) were used to give SGA-16 as colorless crystals (222 mg, 0.605 mmol, 61%). Rf = 0.32 (3:2 hexanes/acetone). m.p.: 220°C [(Sjogren et al., 1991): 218–220°C]. 1H NMR (500 MHz, (CD3)2SO) δ/ppm = 12.31 (s, 1H, NH), 7.81–7.75 (m, 2H, 2’-H, 6’-H), 7.68–7.63 (m, 2H, 2’’-H, 6’’-H), 7.63–7.58 (m, 2H, 3’-H, 5’-H), 7.49–7.44 (m, 2H, 3’’-H, 5’’-H). 13C NMR (126 MHz, (CD3)2SO) δ/ppm = 184.8 (C-3), 167.0 (C-1), 143.5 (C-1’), 139.6 (C-1’’), 134.1 (C-4’’), 129.4 (C-2’’, C-6’’), 127.8 (C-3’’, C-5’’), 126.0 (q, JCF = 3.6 Hz, C-3’, C-5’), 124.6 (q, JCF = 271.0 Hz, CF3), 123.0 (C-2), 121.8 (q, JCF = 31.0 Hz, C-4’), 118.9 (C-2’, C-6’), 77.5 (CN). IR (ATR) V~max/cm−1=3282.2215, 1587, 1240, 1302, 1129, 1113, 1097, 839. HRMS (ESI): calcd. for C17H935ClF3N2O2 (M-H)- 365.03101; found 365.03108. Purity (HPLC): >96% (λ = 210 nm), >96% (λ = 254 nm).\n\nChemical structure 29\n\nAccording to general procedure B, amide SGA-34 (228 mg, 1.00 mmol, 1.0 eq.) in dry THF (10 mL), NaH (92.0 mg, 2.30 mmol, 2.3 eq.) and 2,3,4,5,6-pentafluorobenzoyl chloride (158 µL, 1.10 mmol, 1.1 eq.) were used to give SGA-40 as colorless crystals (236 mg, 0.560 mmol, 56%). Rf = 0.28 (3:2 hexanes/acetone). m.p.: 161°C. 1H NMR (400 MHz, (CD3)2SO) δ/ppm = 11.70 (s, 1H, NH), 7.81–7.72 (m, 2H, 2’-H, 6’-H), 7.67–7.56 (m, 2H, 3’-H, 5’-H). 13C NMR (101 MHz, (CD3)2SO) δ/ppm = 172.6 (C-3), 164.9 (C-1), 143.9–140.9 (m, C-2’’, C-6’’ or C-3’’, C-5’’), 143.3 (C-1’), 141.9–138.9 (m, C-4’’), 138.5–135.1 (m, C-2’’, C-6’’ or C-3’’, C-5’’), 126.1 (q, JCF = 3.6 Hz, C-3’, C-5’), 124.6 (q, JCF = 271.0 Hz, CF3), 122.0 (q, JCF = 31.9 Hz, C-4’), 117.5–117.0 (m, C-1’’), 121.7 (C-2’, C-6’), 118.7 (C-2), 81.8 (CN). IR (ATR) V~max/cm−1=2230, 1590, 1543, 1524, 1497, 1323, 1116, 1000, 839. HRMS (ESI): calcd. for C17H5F8N2O2 (M-H)- 421.02288; found 421.02337. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 30\n\nAccording to general procedure B, amide SGA-34 (228 mg, 1.00 mmol, 1.0 eq.) in dry THF (10 mL), NaH (92.0 mg, 2.30 mmol, 2.3 eq.) and 3,5-dibromobenzoic acid (308 mg, 1.10 mmol, 1.1 eq.; converted into the corresponding aryl chloride) were used to give SGA-70 as light yellow crystals (206 mg, 0.420 mmol, 42%). Rf = 0.32 (3:2 hexanes/acetone). m.p.: 211°C. 1H NMR (400 MHz, (CD3)2SO) δ/ppm = 12.32 (s, 1H, NH), 8.96 (s, 1H, OH), 7.91–7.81 (m, 1H, 4’’-H), 7.78–7.72 (m, 4H, 2’-H, 6’-H, 2’’-H, 6’’-H), 7.65–7.55 (m, 2H, 3’-H, 5’-H). 13C NMR (101 MHz, (CD3)2SO) δ/ppm = 182.5 (C-3), 166.4 (C-1), 145.5 (C-1’’), 143.6 (C-1’), 133.7 (C-4’’), 129.2 (C-2’’, C-6’’), 126.0 (q, JCF = 3.5 Hz, C-3’, C-5’), 123.9 (q, JCF = 271.2 Hz, CF3), 123.3 (C-2), 121.8 (C-3’’, C-5’’), 121.6 (q, JCF = 31.9 Hz, C-4’), 118.5 (C-2’, C-6’), 77.4 (CN). IR (ATR) V~max/cm−1=2218, 1594, 1538, 1315, 1166, 1109, 1068, 838, 750. HRMS (ESI): calcd. for C17H879Br2F3N2O2 (M-H)- 486.89101; found 486.89128. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 31\n\nAccording to general procedure B, amide SGA-34 (228 mg, 1.00 mmol, 1.0 eq.) in dry THF (10 mL), NaH (92.0 mg, 2.30 mmol, 2.3 eq.) and 2,4,6-trichlorobenzoyl chloride (172 µL, 1.10 mmol, 1.1 eq.) were used to give SGA-71 as colorless crystals (158 mg, 0.363 mmol, 36%). Rf = 0.14 (3:2 hexanes/acetone). m.p.: 220°C. 1H NMR (500 MHz, (CD3)2SO) δ/ppm = 11.92 (s, 1H, NH), 7.79–7.74 (m, 2H, 2’-H, 6’-H), 7.66 (s, 2H, 3’’-H, 5’’-H), 7.63–7.58 (m, 2H, 3’-H, 5’-H). 13C NMR (126 MHz, (CD3)2SO) δ/ppm = 180.7 (C-3), 165.7 (C-1), 143.6 (C-1’), 139.5 (C-1’’), 133.1 (C-4’’), 132.0 (C-2’’, C-6’’), 127.8 (C-3’’, C-5’’), 126.1 (q, JCF = 3.6 Hz, C-3’, C-5’), 124.6 (q, JCF = 271.1 Hz, CF3), 121.9 (C-2), 121.6 (q, JCF = 31.9 Hz, C-4’), 118.4 (C-2’, C-6’), 79.5 (CN). IR (ATR) V~max/cm−1=2230, 1598, 1541, 1318, 1116, 841. HRMS (ESI): calcd. for C17H735Cl3F3N2O2 (M-H)- 432.95307; found 432.95394. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 32\n\nAccording to general procedure B, amide SGA-34 (228 mg, 1.00 mmol, 1.0 eq.) in dry THF (10 mL), NaH (92.0 mg, 2.30 mmol, 2.3 eq.) and acetyl chloride (78.5 µL, 1.10 mmol, 1.1 eq.) were used to give SGA-94 as colorless crystals (206 mg, 0.761 mmol, 76%). Analytical data are in accordance with literature (Métro et al., 2012). Rf = 0.65 (3:2 hexanes/acetone). m.p.: 224°C [(Métro et al., 2012): 230–232°C]. 1H NMR (400 MHz, (CD3)2SO) δ/ppm = 12.28 (s, 1H, OH), 10.91 (s, 1H, NH), 7.81–7.72 (m, 2H, 2’-H, 6’-H), 7.70–7.61 (m, 2H, 3’-H, 5’-H), 2.25 (s, 3H, 4 hr). 13C NMR (101 MHz, (CD3)2SO) δ/ppm = 187.1 (C-3), 166.4 (C-1), 141.9 (C-1’), 125.9 (q, JCF = 3.7 Hz, C-3’, C-5’), 124.4 (q, JCF = 271.3 Hz, CF3), 123.5 (q, JCF = 32.1 Hz, C-4’), 120.7 (C-2’, C-6’), 118.9 (C-2), 80.5 (CN), 23.5 (C-4). IR (ATR) V~max/cm−1=2335, 2214, 1551, 1319, 1154, 1113, 840, 679. HRMS (ESI): calcd. for C12H8F3N2O2 (M-H)- 269.05434; found 269.05423. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 33\n\nAccording to general procedure B, amide SGA-34 (228 mg, 1.00 mmol, 1.0 eq.) in dry THF (10 mL), NaH (92.0 mg, 2.30 mmol, 2.3 eq.) and 3,5-bis(trifluoromethyl)benzoyl chloride (199 µL, 1.10 mmol, 1.1 eq.) were used to give SGA-111 as colorless crystals (357 mg, 0.762 mmol, 76%). Rf = 0.43 (3:2 hexanes/acetone). m.p.: 230°C. 1H NMR (400 MHz, (CD3)2SO) δ/ppm = 12.36 (s, 1H, NH), (m, 3H, 2’’-H, 6’’-H, 4’’-H), 7.87–7.71 (m, 2H, 2’-H, 6’-H), 7.69–7.51 (m, 2H, 3’-H, 5’-H). 13C NMR (101 MHz, (CD3)2SO) δ/ppm = 182.4 (C-3), 166.3 (C-1), 144.0 (C-1’’), 143.6 (C-1’), 129.8 (q, JCF = 32.8 Hz, C-3’’, C-5’’), 128.1 (q, JCF = 4.7 Hz, C-2’’, C-6’’), 126.1 (q, JCF = 3.6 Hz, C-3’, C-5’), 126.0 (q, JCF = 257.2 Hz, m-CF3), 123.4 (C-2), 123.3 (q, JCF = 271.6 Hz, p-CF3), 122.7 (q, JCF = 4.0 Hz, C-4’’), 121.7 (q, JCF = 31.9 Hz, C-4’), 118.5 (C-2’, C-6’), 77.7 (CN). IR (ATR) V~max/cm−1=3289, 2218, 1349, 1323, 1284, 1186, 1139, 1114, 836. HRMS (ESI): calcd. for C19H8F9N2O2 (M-H)- 467.04475; found 467.04496. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 34\n\nAccording to general procedure B, amide SGA-34 (228 mg, 1.00 mmol, 1.0 eq.) in dry THF (10 mL), NaH (92.0 mg, 2.30 mmol, 2.3 eq.) and 3,5-dimethylbenzoyl chloride (163 µL, 1.10 mmol, 1.1 eq.) were used to give SGA-112 as colorless crystals (175 mg, 0.486 mmol, 49%). Rf = 0.48 (3:2 hexanes/acetone). m.p.: 187°C. 1H NMR (500 MHz, (CD3)2SO) δ/ppm = 12.08 (s, 1H, NH), 7.85–7.74 (m, 2H, 2’-H, 6’-H), 7.66–7.58 (m, 2H, 3’-H, 5’-H), 7.25 (s, 2H, 2’’-H, 6’’-H), 7.09 (s, 1H,4’’-H), 2.30 (s, 6H, CH3). 13C NMR (126 MHz, (CD3)2SO) δ/ppm = 186.5 (C-3), 167.8 (C-1), 143.6 (C-1’), 140.1 (C-1’’), 137.2 (C-3’’, C-5’’), 131.8 (C-4’’), 126.4 (q, JCF = 3.8 Hz, C-3’, C-5’), 125.8 (C-2’’, C-6’’), 125.3 (q, JCF = 270.8 Hz, CF3), 122.6 (q, JCF = 31.9 Hz, C-4’), 121.8 (C-2), 119.9 (C-2’, C-6’), 78.2 (CN), 21.4 (CH3). IR (ATR) V~max/cm−1=3270, 2218, 1526.1319, 1247, 1157, 1110, 1066, 839. HRMS (ESI): calcd. for C19H14F3N2O2 (M-H)- 359.10129; found 359.10142. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 35\n\nAccording to general procedure B, amide SGA-34 (228 mg, 1.00 mmol, 1.0 eq.) in dry THF (10 mL), NaH (92.0 mg, 2.30 mmol, 2.3 eq.) and 3,5-dimethoxybenzoyl chloride (221 mg, 1.10 mmol, 1.1 eq.) were used to give SGA-113 as colorless crystals (309 mg, 0.789 mmol, 79%). Rf = 0.54 (3:2 hexanes/acetone). m.p.: 203°C. 1H NMR (400 MHz, CDCl3) δ/ppm = 7.99 (s, 1H, NH), 7.73–7.63 (m, 4H, 2’-H, 6’-H, 3’-H, 5’-H), 7.12 (d, J = 2.3 Hz, 2H, 2’’-H, 6’’-H), 6.69 (t, J = 2.3 Hz, 1H, 4’’-H), 3.85 (s, 6H, OCH3). 13C NMR (101 MHz, CDCl3) δ/ppm = 184.1 (C-3), 168.7 (C-1), 161.0 (C-3’’, C-5’’), 139.1 (C-1’), 133.9 (C-1’’), 127.8 (q, JCF = 33.2 Hz, C-4’), 126.7 (q, JCF = 3.8 Hz, C-3’, C-5’), 123.9 (q, JCF = 270.1 Hz, CF3), 121.0 (C-2’, C-6’), 117.5 (C-2), 106.4 (C-2’’, C-6’’), 106.0 (C-4’’), 78.5 (CN), 55.8 (OCH3). IR (ATR) V~max/cm−1=3297, 2215, 1550, 1324, 1208, 1156, 1095, 1067, 834. HRMS (ESI): calcd. for C19H14F3N2O4 (M-H)- 391.09112; found 391.09140. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 36\n\nAccording to general procedure B, amide SGA-34 (228 mg, 1.00 mmol, 1.0 eq.) in dry THF (10 mL), NaH (92.0 mg, 2.30 mmol, 2.3 eq.) and 4-(trifluoromethoxy)benzoyl chloride (173 µL, 1.10 mmol, 1.1 eq.) were used to give SGA-114 as colorless crystals (200 mg, 0.481 mmol, 48%). Rf = 0.58 (3:2 hexanes/acetone). m.p.: 198°C [(Sjogren et al., 1991): 188–190°C]. 1H NMR (500 MHz, CDCl3) δ/ppm = 8.12–8.05 (m, 2H, 2’’-H, 6’’-H), 7.96 (s, 1H, NH), 7.78–7.62 (m, 4H, 2’-H, 6’-H, 3’-H, 5’-H), 7.42–7.32 (m, 2H, 3’’-H, 5’’-H). 13C NMR (126 MHz, CDCl3) δ/ppm = 182.6 (C-3), 168.5 (C-1), 152.8 (C-4’’), 139.0 (C-1’), 130.7 (C-2’’, C-6’’), 130.5 (C-1’’), 128.0 (q, JCF = 33.0 Hz, C-4’), 126.7 (q, JCF = 3.7 Hz, C-3’, C-5’), 123.9 (q, JCF = 271.7 Hz, CF3), 121.0 (C-2’, C-6’), 120.8 (C-3’’, C-5’’), 120.6 (q, JCF = 259.4 Hz, OCF3), 117.3 (C-2), 78.6 (CN). IR (ATR) V~max/cm−1=3285, 2215, 1597, 1551, 1505, 1268, 1168, 1128, 839. HRMS (ESI): calcd. for C18H9F6N2O3 (M-H)- 415.05228; found 415.05225. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 37\n\nAccording to general procedure B, amide SGA-34 (228 mg, 1.00 mmol, 1.0 eq.) in dry THF (10 mL), NaH (92.0 mg, 2.30 mmol, 2.3 eq.) and nicotinoyl chloride hydrochloride (196 mg, 1.10 mmol, 1.1 eq.) were used to give SGA-127 as orange solid (169 mg, 0.506 mmol, 51%). Rf = 0.00 (3:2 hexanes/EtOAc). m.p.: 235°C. 1H NMR (400 MHz, (CD3)2SO) δ/ppm = 12.22 (s, 1H, NH), 9.12 (s, 1H, 2’’-H), 8.88 (d, J = 5.6 Hz, 1H, 6’’-H), 8.70 (d, J = 8.0 Hz, 1H, 4’’-H), 8.04 (dd, J = 8.0, 5.6 Hz, 1H, 5’’-H), 7.83–7.72 (m, 2H, 2’-H, 6’-H), 7.67–7.56 (m, 2H, 3’-H, 5’-H). 13C NMR (101 MHz, (CD3)2SO) δ/ppm = 180.0 (C-3), 165.9 (C-1), 143.5 (C-1’), 143.3 (C-6’’), 143.0 (C-4’’), 141.9 (C-2’’), 139.9 (C-3’’), 126.2 (C-5’’), 126.1 (q, JCF = 3.6 Hz, C-3’, C-5’), 124.2 (q, JCF = 270.7 Hz, CF3), 123.3 (C-2), 121.8 (q, JCF = 32.0 Hz, C-4’), 118.5 (C-2’, C-6’), 78.5 (CN). IR (ATR) V~max/cm−1=2356, 2191, 1533, 1317, 1105, 1060, 849, 698. HRMS (ESI): calcd. for C16H9F3N3O2 (M-H)- 332.06523; found 332.06517. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 38\n\nAccording to general procedure B, amide SGA-34 (228 mg, 1.00 mmol, 1.0 eq.) in dry THF (10 mL), NaH (92.0 mg, 2.30 mmol, 2.3 eq.) and 3-bromo-5-iodobenzoic acid (360 mg, 1.10 mmol, 1.1 eq.; converted into the corresponding aryl chloride) were used to give SGA-132 as colorless crystals (332 mg, 0.618 mmol, 62%). Rf = 0.38 (3:2 hexanes/EtOAc). m.p.: 207°C. 1H NMR (400 MHz, (CD3)2SO) δ/ppm = 12.31 (s, 1H, NH), 7.97 (s, 1H, 4’’-H), 7.89 (s, 1H, 2’’-H or 6’’-H), 7.78–7.72 (m, 3H, 2’-H, 6’-H and 2’’-H or 6’’-H), 7.63–7.55 (m, 2H, 3’-H, 5’-H). 13C NMR (101 MHz, (CD3)2SO) δ/ppm = 182.6 (C-3), 166.4 (C-1), 145.4 (C-1’’), 143.6 (C-1’), 139.1 (C-4’’), 135.0 (C-2’’ or C-6’’), 129.5 (C-2’’ or C-6’’), 126.0 (q, JCF = 3.8 Hz, C-3’, C-5’), 123.9 (q, JCF = 263.8 Hz, CF3), 123.3 (C-2), 121.7 (q, JCF = 31.6 Hz, C-4’), 121.6 (C-3’’ or C-5’’), 118.6 (C-2’, C-6’), 95.0 (C-3’’ or C-5’’), 77.4 (CN). IR (ATR) V~max/cm−1=3276, 2213, 1532, 1318, 1163, 1112, 731. HRMS (ESI): calcd. for C17H879BrIF3N2O2 (M-H)- 534.87714; found 534.87813. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 39\n\nAccording to general procedure B, amide SGA-34 (228 mg, 1.00 mmol, 1.0 eq.) in dry THF (10 mL), NaH (92.0 mg, 2.30 mmol, 2.3 eq.) and 5-chloronicotinic acid (173 mg, 1.10 mmol, 1.1 eq.; converted into the corresponding aryl chloride) were used to give SGA-136 as light pink crystals (225 mg, 0.611 mmol, 61%). Rf = 0.15 (3:2 hexanes/acetone). m.p.: 221°C. 1H NMR (500 MHz, (CD3)2SO) δ/ppm = 12.33 (s, 1H, NH), 8.74 (s, 1H, 2’’-H or 4’’-H), 8.69–8.64 (m, 1H, 6’’-H), 8.11–8.05 (m, 1H, 2’’-H or 4’’-H), 7.81–7.73 (m, 2H, 2’-H, 6’-H), 7.64–7.55 (m, 2H, 3’-H, 5’-H). 13C NMR (126 MHz, (CD3)2SO) δ/ppm = 181.7 (C-3), 166.2 (C-1), 147.9 (C-6’’), 146.1 (C-2’’ or C-4’’), 143.6 (C-1’), 138.8 (C-3’’ or C-5’’), 134.9 (C-2’’ or C-4’’), 130.5 (C-3’’ or C-5’’), 126.1 (q, JCF = 3.7 Hz, C-3’, C-5’), 124.6 (q, JCF = 271.0 Hz, CF3), 123.5 (C-2), 121.6 (q, JCF = 31.5 Hz, C-4’), 118.5 (C-2’, C-6’), 78.2 (CN). IR (ATR) V~max/cm−1=3285, 2225, 1539, 1308, 1113, 951, 838. HRMS (ESI): calcd. for C16H835ClF3N3O2 (M-H)- 366.02626; found 366.02652. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 40\n\nAccording to general procedure B, amide SGA-34 (228 mg, 1.00 mmol, 1.0 eq.) in dry THF (10 mL), NaH (92.0 mg, 2.30 mmol, 2.3 eq.) and 1-methylpyrrole-2-carbonyl chloride (158 mg, 1.10 mmol, 1.1 eq.) were used to give SGA-32 as colorless crystals (221 mg, 0.660 mmol, 66%). Rf = 0.57 (3:2 hexanes/acetone). m.p.: 203°C. 1H NMR (400 MHz, CDCl3) δ/ppm = 7.86 (s, 1H, NH), 7.69–7.61 (m, 4H, 2’-H, 6’-H, 3’-H, 5’-H), 7.57 (dd, J = 4.3, 1.6 Hz, 1H, 3’’-H), 6.93–6.90 (m, 1H, 4’’-H), 6.27 (dd, J = 4.3, 2.5 Hz, 1H, 5’’-H), 3.93 (s, 3H, CH3). 13C NMR (101 MHz, CDCl3) δ/ppm = 175.6 (C-3), 170.2 (C-1), 139.5 (C-1’), 132.6 (C-5’’), 127.4 (q, JCF = 31.8 Hz, C-4’), 126.6 (q, J = 3.8 Hz, C-3’, C-5’), 124.1 (C-2’’), 124.0 (q, JCF = 271.4 Hz, CF3), 121.3 (C-3’’), 120.7 (C-2’, C-6’), 119.0 (C-2), 110.0 (C-4’’), 72.6 (CN), 38.7 (CH3). IR (ATR) V~max/cm−1=3273, 2210, 1518, 1379, 1228, 1111, 996, 837, 745. HRMS (ESI): calcd. for C16H11F3N3O2 (M-H)- 334.08088; found 334.08090. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 41\n\nAccording to general procedure B, amide 2 (228 mg, 1.00 mmol, 1.0 eq.) in dry THF (10 mL), NaH (92.0 mg, 2.30 mmol, 2.3 eq.) and 1-methylpyrrole-2-carbonyl chloride (158 mg, 1.10 mmol, 1.1 eq.) were used to give SGA-31 as colorless crystals (200 mg, 0.747 mmol, 75%). Rf = 0.65 (3:2 hexanes/acetone). m.p.: 171°C [(Walker, 1981): 174–175°C]. 1H NMR (400 MHz, CDCl3) δ/ppm = 7.74 (s, 1H, NH), 7.54 (dd, J = 4.3, 1.6 Hz, 1H, 3’’-H), 7.50 (d, J = 8.0 Hz, 2H, 2’-H, 6’-H), 7.44–7.34 (m, 2H, 3’-H, 5’-H), 7.20 (t, J = 7.4 Hz, 1H, 4’-H), 6.89 (t, J = 1.9 Hz, 1H, 5’’-H), 6.25 (dd, J = 4.3, 2.5 Hz, 1H, 4’’-H), 3.92 (s, 3H, CH3). 13C NMR (101 MHz, CDCl3) δ/ppm = 175.6 (C-3), 170.0 (C-1), 136.2 (C-1’), 132.0 (C-5’’), 129.3 (C-3’, C-5’), 125.7 (C-4’), 124.4 (C-2’’), 121.3 (C-2’, C-6’), 120.7 (C-3’’), 119.1 (C-2), 109.7 (C-4’’), 72.6 (CN), 38.5 (CH3). IR (ATR) V~max/cm−1=3293, 2210, 1526, 1382, 1231, 751, 736, 687. HRMS (ESI): calcd. for C15H12N3O2 (M-H)- 266.09350; found 266.09370. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 42\n\nAccording to general procedure B, amide 2 (160 mg, 1.00 mmol, 1.0 eq.) in dry THF (10 mL), NaH (92.0 mg, 2.30 mmol, 2.3 eq.) and 3,5-dichlorobenzoyl chloride (230 mg, 1.10 mmol, 1.1 eq.) were used to give SGA-1 as yellow solid (227 mg, 0.681 mmol, 68%). Rf = 0.67 (3:2 hexanes/acetone). m.p.: 200°C. 1H NMR (500 MHz, (CD3)2SO) δ/ppm = 11.95 (s, 1H, NH), 7.61 (t, J = 1.9 Hz, 1H, 4’’-H), 7.56 (d, J = 1.9 Hz, 2H, 2’’-H, 6’’-H), 7.53 (dd, J = 8.5, 1.0 Hz, 2H, 2’-H, 6’-H), 7.27–7.22 (m, 2H, 3’-H, 5’-H), 6.96–6.90 (m, 1H, 4’-H). 13C NMR (126 MHz, (CD3)2SO) δ/ppm = 182.2 (C-3), 166.1 (C-1), 145.3 (C-1’’), 140.1 (C-1’), 133.4 (C-3’’, C-5’’), 128.7 (C-3’, C-5’), 128.3 (C-4’’), 126.1 (C-2’’, C-6’’), 123.6 (C-2), 121.7 (C-4’), 118.8 (C-2’, C-6’), 77.4 (CN). IR (ATR) V~max/cm−1=3294, 2212, 1579, 1445, 810, 748, 683. HRMS (ESI): calcd. for C16H935Cl2N2O2 (M-H)- 331.00466; found 331.00465. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 43\n\nAccording to general procedure B, amide 1 (174 mg, 1.00 mmol, 1.0 eq.) in dry THF (10 mL), NaH (92.0 mg, 2.30 mmol, 2.3 eq.) and 3,5-dichlorobenzoyl chloride (230 mg, 1.10 mmol, 1.1 eq.) were used to give SGA-4 as yellow crystals (185 mg, 0.534 mmol, 53%). Rf = 0.28 (3:2 hexanes/acetone). m.p.: 214°C. 1H NMR (400 MHz, (CD3)2SO) δ/ppm = 11.82 (s, 1H, NH), 7.63 (t, J = 1.9 Hz, 1H, 4’’-H), 7.56 (d, J = 1.9 Hz, 2H, 2’’-H, 6’’-H), 7.46–7.39 (m, 2H, 2’-H, 6’-H), 7.09–7.02 (m, 2H, 3’-H, 5’-H), 2.24 (s, 3H, CH3). 13C NMR (101 MHz, (CD3)2SO) δ/ppm = 182.0 (C-3), 166.0 (C-1), 145.1 (C-1’’), 137.4 (C-1’), 133.4 (C-3’’, C-5’’), 130.6 (C-4’), 129.1 (C-3’, C-5’), 128.3 (C-4’’), 126.1 (C-2’’, C-6’’), 123.5 (C-2), 119.0 (C-2’, C-6’), 77.5 (CN), 20.4 (CH3). IR (ATR) V~max/cm−1=3299, 2212, 1543, 1518.866, 806, 654. HRMS (ESI): calcd. for C17H1135Cl2N2O2 (M-H)- 345.02031; found 345.02052. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 44\n\nAccording to general procedure B, amide 1 (174 mg, 1.00 mmol, 1.0 eq.) in dry THF (10 mL), NaH (92.0 mg, 2.30 mmol, 2.3 eq.) and 3,5-bis(trifluoromethyl)benzoyl chloride (199 µL, 1.10 mmol, 1.1 eq.) were used to give SGA-108 as light yellow crystals (208 mg, 0.502 mmol, 50%). Rf = 0.28 (3:2 hexanes/acetone). m.p.: 183°C. 1H NMR (500 MHz, CDCl3) δ/ppm = 8.45 (s, 2H, 2’’-H, 6’’-H), 8.10 (s, 1H, 4’’-H), 7.86 (s, 1H, NH), 7.43–7.37 (m, 2H, 2’-H, 6’-H), 7.25–7.20 (m, 2H, 3’-H, 5’-H), 2.37 (s, 3H, CH3). 13C NMR (126 MHz, CDCl3) δ/ppm = 180.4 (C-3), 167.9 (C-1), 136.7 (C-4’), 134.7 (C-1’’), 132.7 (C-1’), 132.6 (q, JCF = 34.2 Hz, C-3’’, C-5’’), 130.1 (C-3’, C-5’), 128.6 (q, JCF = 3.1 Hz, C-2’’, C-6’’), 126.3 (q, JCF = 3.7 Hz, C-4’’), 122.8 (q, JCF = 272.9 Hz, CF3), 121.8 (C-2’, C-6’), 116.5 (C-2), 79.7 (CN), 21.2 (CH3). IR (ATR) V~max/cm−1=3276, 2213, 1538, 1278, 1129, 811, 681. HRMS (ESI): calcd. for C19H11F6N2O2 (M-H)- 413.07302; found 413.07301. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 45\n\nAccording to general procedure B, amide 4 (195 mg, 1.00 mmol, 1.0 eq.) in dry THF (10 mL), NaH (92.0 mg, 2.30 mmol, 2.3 eq.) and 3,5-dichlorobenzoyl chloride (230 mg, 1.10 mmol, 1.1 eq.) were used to give SGA-2 as yellow solid (256 mg, 0.695 mmol, 70%). Rf = 0.71 (3:2 hexanes/acetone). m.p.: 230°C. 1H NMR (500 MHz, (CD3)2SO) δ/ppm = 12.12 (s, 2H, NH), 7.62 (t, J = 1.9 Hz, 1H, 4’’-H), 7.60–7.57 (m, 2H, 2’-H, 6’-H), 7.55 (d, J = 1.9 Hz, 2H, 2’’-H, 6’’-H), 7.30–7.26 (m, 2H, 3’-H, 5’-H). 13C NMR (126 MHz, (CD3)2SO) δ/ppm = 182.5 (C-3), 166.1 (C-1), 145.4 (C-1’’), 139.1 (C-1’), 133.4 (C-3’’, C-5’’), 128.6 (C-3’, C-5’), 128.3 (C-4’’), 126.0 (C-2’’, C-6’’), 125.0 (C-4’), 123.6 (C-2), 120.2 (C-2’, C-6’), 77.2 (CN). IR (ATR) V~max/cm−1=3305, 2212, 1545, 1495, 1506, 1316, 1098, 809. HRMS (ESI): calcd. for C16H835Cl3N2O2 (M-H)- 364.96568; found 364.96593. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 46\n\nAccording to general procedure B, amide 5 (239 mg, 1.00 mmol, 1.0 eq.) in dry THF (10 mL), NaH (92.0 mg, 2.30 mmol, 2.3 eq.) and 3,5-dichlorobenzoyl chloride (230 mg, 1.10 mmol, 1.1 eq.) were used to give SGA-3 as yellow crystals (289 mg, 0.702 mmol, 70%). Rf = 0.73 (3:2 hexanes/acetone). m.p.: 237°C. 1H NMR (400 MHz, (CD3)2SO) δ/ppm = 12.09 (s, 1H, NH), 7.62 (t, J = 1.9 Hz, 1H, 4’’-H), 7.58–7.51 (m, 4H, 2’-H, 6’-H, 2’’-H, 6’’-H), 7.44–7.38 (m, 2H, 3’-H, 5’-H).13C NMR (101 MHz, (CD3)2SO) δ/ppm = 182.4 (C-3), 166.1 (C-1), 145.2 (C-1’’), 139.4 (C-1’), 133.4 (C-3’’, C-5’’), 131.4 (C-3’, C-5’), 128.3 (C-4’’), 126.0 (C-2’’, C-6’’), 122.6 (C-2), 120.7 (C-2’, C-6’), 112.9 (C-4’), 77.4 (CN). IR (ATR) V~max/cm−1=3309, 2211, 1540, 1493, 1403, 1316, 1290, 1012, 809. HRMS (ESI): calcd. for C16H879Br35Cl2N2O2 (M-H)- 408.91517; found 408.91581. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 47\n\nAccording to general procedure B, amide 5 (239 mg, 1.00 mmol, 1.0 eq.) in dry THF (10 mL), NaH (92.0 mg, 2.30 mmol, 2.3 eq.) and 3,5-dibromobenzoic acid (308 mg, 1.10 mmol, 1.1 eq.; converted into the corresponding aryl chloride) were used to give SGA-75 as colorless crystals (222 mg, 0.443 mmol, 44%). Rf = 0.20 (3:2 hexanes/acetone). m.p.: 233°C. 1H NMR (400 MHz, (CD3)2SO) δ/ppm = 12.05 (s, 1H, NH), 7.86 (t, J = 1.8 Hz, 1H, 4’-H), 7.73 (d, J = 1.8 Hz, 2H, 2’’-H, 6’’-H), 7.57–7.50 (m, 2H, 2’-H, 6’-H), 7.46–7.37 (m, 2H, 3’-H, 5’-H). 13C NMR (101 MHz, (CD3)2SO) δ/ppm = 182.2 (C-3), 166.1 (C-1), 145.5 (C-1’’), 139.4 (C-1’), 133.7 (C-4’’), 131.5 (C-3’, C-5’), 129.2 (C-2’’, C-6’’), 122.7 (C-2), 121.8 (C-3’’, C-5’’), 120.8 (C-2’, C-6’), 113.0 (C-4’), 77.4 (CN). IR (ATR) V~max/cm−1=3314, 2214, 1596, 1543, 865, 817, 748, 658. HRMS (ESI): calcd. for C16H879Br3N2O2 (M-H)- 496.81414; found 496.81449. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 48\n\nAccording to general procedure B, amide 5 (239 mg, 1.00 mmol, 1.0 eq.) in dry THF (10 mL), NaH (92.0 mg, 2.30 mmol, 2.3 eq.) and 2,4,6-trichlorobenzoyl chloride (172 µL, 1.10 mmol, 1.1 eq.) were used to give SGA-72 as colorless solid (227 mg, 0.507 mmol, 51%). Rf = 0.14 (3:2 hexanes/acetone). m.p.: 191°C. 1H NMR (400 MHz, (CD3)2SO) δ/ppm = 11.69 (s, 1H, NH), 7.65 (s, 2H, 3’’-H, 5’’-H), 7.58–7.52 (m, 2H, 2’-H, 6’-H), 7.44–7.38 (m, 2H, 3’-H, 5’-H). 13C NMR (101 MHz, (CD3)2SO) δ/ppm = 180.3 (C-3), 165.4 (C-1), 139.6 (C-1’ or C-1’’), 139.4 (C-1’ or C-1’’), 133.0 (C-4’’), 132.0 (C-2’’, C-6’’), 131.5 (C-3’, C-5’), 127.8 (C-3’’, C-5’’), 122.1 (C-2), 120.5 (C-2’, C-6’), 112.9 (C-4’), 79.5 (CN). IR (ATR) V~max/cm−1=2238, 1588, 1539, 1488, 1307, 856, 818. HRMS (ESI): calcd. for C16H779Br35Cl3N2O2 (M-H)- 442.87620; found 442.87747. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 49\n\nAccording to general procedure B, amide 6 (178 mg, 1.00 mmol, 1.0 eq.) in dry THF (10 mL), NaH (92.0 mg, 2.30 mmol, 2.3 eq.) and 3,5-dichlorobenzoyl chloride (230 mg, 1.10 mmol, 1.1 eq.) were used to give SGA-8 as white crystals (220 mg, 0.626 mmol, 63%). Rf = 0.69 (3:2 hexanes/acetone). m.p.: 225°C. 1H NMR (400 MHz, (CD3)2SO) δ/ppm = 11.92 (s, 1H, NH), 7.63 (t, J = 1.9 Hz, 1H, 4’’-H), 7.60–7.53 (m, 4H, 2’-H, 6’-H, 2’’-H, 6’’-H), 7.12–7.03 (m, 2H, 3’-H, 5’-H). 13C NMR (101 MHz, (CD3)2SO) δ/ppm = 182.2 (C-3), 166.1 (C-1), 157.3 (d, JCF = 236.9 Hz, C-4’), 144.9 (C-1’’), 136.3 (d, JCF = 2.4 Hz, C-1’), 133.4 (C-3’’, C-5’’), 128.4 (C-4’’), 126.1 (C-2’’, C-6’’), 123.3 (C-2), 120.5 (d, JCF = 7.6 Hz, C-2’, C-6’), 115.2 (d, JCF = 22.0 Hz, C-3’, C-5’), 77.4 (CN). IR (ATR) V~max/cm−1=3296, 2212, 1739, 1549, 1506, 1210, 823, 809, 645. HRMS (ESI): calcd. for C16H835Cl2FN2O2 (M-H)- 348.99523; found 348.99526. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 50\n\nAccording to general procedure B, amide 7 (286 mg, 1.00 mmol, 1.0 eq.) in dry THF (10 mL), NaH (92.0 mg, 2.30 mmol, 2.3 eq.) and 3,5-dichlorobenzoyl chloride (230 mg, 1.10 mmol, 1.1 eq.) were used to give SGA-9 as yellow crystals (279 mg, 0.608 mmol, 61%). Rf = 0.71 (3:2 hexanes/acetone). m.p.: 238°C. 1H NMR (400 MHz, (CD3)2SO) δ/ppm = 12.04 (s, 1H, NH), 7.63 (t, J = 1.9 Hz, 1H, 4’’-H), 7.59–7.53 (m, 4H, 3’-H, 5’-H, 2’’-H, 6’’-H), 7.44–7.38 (m, 2H, 2’-H, 6’-H). 13C NMR (101 MHz, (CD3)2SO) δ/ppm = 182.4 (C-3), 166.2 (C-1), 145.1 (C-1’’), 139.8 (C-1’), 137.3 (C-3’, C-5’ or C-2’’, C-6’’), 133.4 (C-3’’, C-5’’), 128.4 (C-4’’), 126.1 (C-3’, C-5’ or C-2’’, C-6’’), 123.3 (C-2), 121.1 (C-2’, C-6’), 84.5 (C-4’), 77.5 (CN). IR (ATR) V~max/cm−1=3303, 2217, 1592, 1523, 1485, 1314, 817, 806, 658. HRMS (ESI): calcd. for C16H835Cl2IN2O2 (M-H)- 456.90130; found 456.90014. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 51\n\nAccording to general procedure B, amide 8 (205 mg, 1.00 mmol, 1.0 eq.) in dry THF (16 mL), NaH (92.0 mg, 2.30 mmol, 2.3 eq.) and 3,5-dichlorobenzoyl chloride (230 mg, 1.10 mmol, 1.1 eq.) were used to give SGA-13 as yellow solid (208 mg, 0.550 mmol, 55%). Rf = 0.82 (3:2 hexanes/acetone). m.p.: 246°C. 1H NMR (400 MHz, (CD3)2SO) δ/ppm = 12.64 (s, 1H, NH), 8.19–8.13 (m, 2H, 3’-H, 5’-H), 7.82–7.77 (m, 2H, 2’-H, 6’-H), 7.64 (t, J = 1.9 Hz, 1H, 4’’-H), 7.57 (d, J = 1.9 Hz, 2H, 2’’-H, 6’’-H). 13C NMR (101 MHz, (CD3)2SO) δ/ppm = 181.6 (C-3), 166.9 (C-1), 149.4 (C-1’’), 147.0 (C-1’), 141.3 (C-4’), 133.9 (C-3’’, C-5’’), 129.0 (C-4’’), 126.5 (C-2’’, C-6’’), 125.7 (C-3’, C-5’), 121.8 (C-2), 118.6 (C-2’, C-6’), 77.0 (CN). IR (ATR) V~max/cm−1=3314, 2209, 1568, 1546, 1514, 1498, 1340, 1309, 847, 813, 656. HRMS (ESI): calcd. for C16H835Cl2N3O4 (M-H)- 375.98973; found 375.98970. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 52\n\nAccording to general procedure B, amide 3 (190 mg, 1.00 mmol, 1.0 eq.) in dry THF (10 mL), NaH (92.0 mg, 2.30 mmol, 2.3 eq.) and 3,5-dichlorobenzoyl chloride (230 mg, 1.10 mmol, 1.1 eq.) were used to give SGA-12 as yellow solid (220 mg, 0.606 mmol, 61%). Rf = 0.76 (3:2 hexanes/acetone). m.p.: 207°C. 1H NMR (400 MHz, (CD3)2SO) δ/ppm = 11.36 (s, 1H, NH), 9.87 (s, 1H, OH), 7.71 (t, J = 1.8 Hz, 1H, 4’-H), 7.65 (d, J = 1.8 Hz, 2H, 2’’-H, 6’’-H), 7.49–7.41 (m, 2H, 2’-H, 6’-H), 6.90–6.85 (m, 2H, 3’-H, 5’-H), 3.72 (s, 3H, OCH3). 13C NMR (101 MHz, (CD3)2SO) δ/ppm = 181.6 (C-3), 166.4 (C-1), 155.2 (C-4’), 142.6 (C-1’’), 133.7 (C-3’’, C-5’’), 131.9 (C-1’), 129.3 (C-4’’), 126.3 (C-2’’, C-6’’), 121.7 (C-2’, C-6’), 121.4 (C-2), 113.9 (C-3’, C-5’), 78.1 (CN), 55.2 (OCH3). IR (ATR) V~max/cm−1=3296, 2211, 1601, 1467, 1441, 1297, 1251, 1032, 764. HRMS (ESI): calcd. for C17H1135Cl2N2O3 (M-H)- 361.01522; found 361.01516. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 53\n\nAccording to general procedure B, amide 9 (185 mg, 1.00 mmol, 1.0 eq.) in dry THF (10 mL), NaH (92.0 mg, 2.30 mmol, 2.3 eq.) and 3,5-dichlorobenzoyl chloride (230 mg, 1.10 mmol, 1.1 eq.) were used to give SGA-38 as yellow solid (137 mg, 0.382 mmol, 38%). Rf = 0.12 (3:2 hexanes/acetone). m.p.: 236°C. 1H NMR (500 MHz, (CD3)2SO) δ/ppm = 12.42 (s, 1H, NH), 7.75–7.72 (m, 2H, 3’-H, 5’-H), 7.71–7.67 (m, 2H, 2’-H, 6’-H), 7.64 (t, J = 1.9 Hz, 1H, 4’’-H), 7.57 (d, J = 1.9 Hz, 2H, 2’’-H, 6’’-H). 13C NMR (126 MHz, (CD3)2SO) δ/ppm = 183.0 (C-3), 166.4 (C-1), 145.1 (C-1’’), 144.3 (C-1’), 133.5 (C-3’’, C-5’’), 133.3 (C-3’, C-5’), 128.5 (C-4’’), 126.0 (C-2’’, C-6’’), 123.2 (C-4’), 119.4 (C-2), 118.8 (C-2’, C-6’), 103.1 (4’-CN), 77.4 (2-CN). IR (ATR) V~max/cm−1=3321, 2360, 2340, 1533, 839, 655. HRMS (ESI): calcd. for C17H835Cl2N3O2 (M-H)- 355.99991; found 356.00057. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 54\n\nAccording to general procedure B, amide 10 (202 mg, 1.00 mmol, 1.0 eq.) in dry THF (10 mL), NaH (92.0 mg, 2.30 mmol, 2.3 eq.) and 3,5-dichlorobenzoyl chloride (230 mg, 1.10 mmol, 1.1 eq.) were used to give SGA-76 as off white solid (296 mg, 0.789 mmol, 79%). Rf = 0.08 (3:2 hexanes/acetone). m.p.: 209°C. 1H NMR (500 MHz, (CD3)2SO) δ/ppm = 12.32 (s, 1H, NH), 7.91–7.86 (m, 2H, 3’-H, 5’-H), 7.71–7.66 (m, 2H, 2’-H, 6’-H), 7.64 (t, J = 1.9 Hz, 1H, 4’’-H), 7.58 (d, J = 1.9 Hz, 2H, 2’’-H, 6’’-H), 2.51 (s, 3H, CH3, collapses with DMSO). 13C NMR (101 MHz, (CD3)2SO) δ/ppm = 196.3 (CO), 182.8 (C-3), 166.3 (C-1), 145.1 (C-1’’), 144.5 (C-1’), 133.5 (C-3’’, C-5’’), 130.4 (C-4’), 129.7 (C-3’, C-5’), 128.5 (C-4’’), 126.1 (C-2’’, C-6’’), 123.3 (C-2), 117.9 (C-2’, C-6’), 77.6 (CN), 26.3 (CH3). IR (ATR) V~max/cm−1=3304, 2207, 1682, 1596, 1544, 1355, 1272, 809. HRMS (ESI): calcd. for C18H1135Cl2N2O3 (M-H)- 373.01522; found 373.01580. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 55\n\nAccording to general procedure B, amide 11 (218 mg, 1.00 mmol, 1.0 eq.) in dry THF (10 mL), NaH (92.0 mg, 2.30 mmol, 2.3 eq.) and 3,5-dichlorobenzoyl chloride (230 mg, 1.10 mmol, 1.1 eq.) were used to give SGA-84 as yellow solid (245 mg, 0.626 mmol, 63%). Rf = 0.15 (3:2 hexanes/acetone + 2% TEA). m.p.: 184°C. 1H NMR (500 MHz, (CD3)2SO) δ/ppm = 11.36 (s, 1H, NH), 9.30 (s, 1H, OH), 7.71 (t, J = 1.7 Hz, 1H, 4’’-H), 7.67–7.62 (m, 2H, 2’’-H, 6’’-H), 7.49–7.40 (m, 2H, 3’-H, 5’-H), 6.90–6.82 (m, 2H, 2’-H, 6’-H), 3.88 (t, J = 6.5 Hz, 2H, CH2CH2CH3), 1.71 (sext, J = 7.2 Hz, 2H, CH2CH2CH3), 0.97 (t, J = 7.4 Hz, 3H, CH2CH2CH3). 13C NMR (126 MHz, (CD3)2SO) δ/ppm = 181.6 (C-3), 166.4 (C-1), 154.6 (C-4’), 142.7 (C-1’’), 133.7 (C-3’’, C-5’’), 131.9 (C-1’), 129.3 (C-4’’), 126.3 (C-2’’, C-6’’), 121.6 (C-3’, C-5’), 121.5 (C-2), 114.5 (C-2’, C-6’), 78.0 (CN), 69.1 (CH2CH2CH3), 22.1 (CH2CH2CH3), 10.4 (CH2CH2CH3). IR (ATR) V~max/cm−1=3304, 2208, 1601, 1550, 1511, 1249, 1235, 822, 811. HRMS (ESI): calcd. for C19H1535Cl2N2O3 (M-H)- 389.04652; found 389.04631. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 56\n\nAccording to general procedure B, amide 12 (244 mg, 1.00 mmol, 1.0 eq.) in dry THF (10 mL), NaH (92.0 mg, 2.30 mmol, 2.3 eq.) and 3,5-dichlorobenzoyl chloride (230 mg, 1.10 mmol, 1.1 eq.) were used to give SGA-86 as colorless solid (344 mg, 0.825 mmol, 83%). Rf = 0.53 (3:2 hexanes/acetone). m.p.: 195°C. 1H NMR (500 MHz, (CD3)2SO) δ/ppm = 12.02 (s, 1H, NH), 9.41 (s, 1H, OH), 7.69–7.64 (m, 3H, 2’-H, 6’-H, 4’’-H), 7.59 (d, J = 1.9 Hz, 2H, 2’’-H, 6’’-H), 7.28–7.23 (m, 2H, 3’-H, 5’-H). 13C NMR (126 MHz, (CD3)2SO) δ/ppm = 182.3 (C-3), 166.3 (C-1), 144.6 (C-1’’), 142.7 (C-4’), 139.1 (C-1’), 133.5 (C-3’’, C-5’’), 128.6 (C-4’’), 126.1 (C-2’’, C-6’’), 123.0 (C-2), 121.6 (C-3’, C-5’), 120.3 (q, JCF = 255.2 Hz, OCF3), 120.2 (C-2’, C-6’), 77.6 (CN). IR (ATR) V~max/cm−1=3304, 2218, 1614, 1536, 1506, 1262, 1208, 1164, 661. HRMS (ESI): calcd. for C17H835Cl2F3N2O3 (M-H)- 414.98696; found 414.98676. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 57\n\nAccording to general procedure B, amide 13 (218 mg, 1.00 mmol, 1.0 eq.) in dry THF (10 mL), NaH (92.0 mg, 2.30 mmol, 2.3 eq.) and 3,5-dichlorobenzoyl chloride (230 mg, 1.10 mmol, 1.1 eq.) were used. The resulting solid was washed with hexanes, EtOH and water to give SGA-133 as colorless solid (331 mg, 0.846 mmol, 85%). Rf = 0.15 (3:2 hexanes/acetone). m.p.: 234°C. 1H NMR (400 MHz, (CD3)2SO) δ/ppm = 12.33 (s, 1H, NH), 11.41 (s, 1H, OH), 7.90–7.83 (m, 2H, 2 hr, 6 hr), 7.71–7.66 (m, 2H, 3 hr, 5 hr), 7.64 (t, J = 1.9 Hz, 1H, 4’’-H), 7.57 (d, J = 1.9 Hz, 2H, 2’’-H, 6’’-H), 3.81 (s, 3H, CH3). 13C NMR (101 MHz, (CD3)2SO) δ/ppm = 182.8 (C-3’), 166.3 (C-1’), 166.0 (CO), 145.1 (C-1’’), 144.6 (C-4), 133.4 (C-3’’, C-5’’), 130.4 (C-2, C-6), 128.5 (C-4’’), 126.1 (C-2’’, C-6’’), 123.3 (C-2’), 122.3 (C-1), 118.1 (C-3, C-5), 77.6 (CN), 51.7 (CH3). IR (ATR) V~max/cm−1=3304, 3093, 2215, 1727, 1591, 1534, 1415, 1283, 1262, 1112, 810, 766. HRMS (ESI): calcd. for C18H1135Cl2N2O4 (M-H)- 389.01014; found 389.01077. Purity (NMR):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 58\n\nEster SGA-133 (95.0 mg, 0.243 mmol, 1.0 eq.) was dissolved in dioxane/H2O (3:1; 4.0 mL) and LiOH (61.2 mg, 2.43 mmol, 10 eq.) was added. The mixture was stirred at rt for 3 hr, before 1 M aq. HCl (5.0 mL) was added. The precipitate was filtered off, washed with cold water and dried to give SGA-137 as colorless solid (59.6 mg, 0.158 mmol, 65%). Rf = 0.00 (3:2 hexanes/acetone). m.p.: 244°C. 1H NMR (500 MHz, (CD3)2SO) δ/ppm = 12.30 (s, 1H, NH), 7.87–7.81 (m, 2H, 2 hr, 6 hr), 7.68–7.64 (m, 2H, 3 hr, 5 hr), 7.63 (t, J = 1.9 Hz, 1H, 4’’-H), 7.57 (d, J = 1.9 Hz, 2H, 2’’-H, 6’’-H). 13C NMR (126 MHz, (CD3)2SO) δ/ppm = 182.7 (C-3’), 167.1 (CO), 166.3 (C-1’), 145.2 (C-1’’), 144.2 (C-4), 133.4 (C-3’’, C-5’’), 130.5 (C-2, C-6), 128.4 (C-4’’), 126.1 (C-2’’, C-6’’), 123.5 (C-1), 123.4 (C-2’), 118.0 (C-3, C-5), 77.5 (CN). IR (ATR) V~max/cm−1=3311, 2215, 1696, 1595, 1550, 1415, 1294, 855, 770. HRMS (ESI): calcd. for C17H935Cl2N2O4 (M-H)- 374.99449; found 374.99480. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 59\n\nAccording to general procedure B, amide 14 (274 mg, 1.00 mmol, 1.0 eq.) in dry THF (10 mL), NaH (92.0 mg, 2.30 mmol, 2.3 eq.) and 3,5-dichlorobenzoyl chloride (230 mg, 1.10 mmol, 1.1 eq.) were used to give SGA-27 as colorless solid (330 mg, 0.738 mmol, 74%). Rf = 0.25 (3:2 hexanes/acetone). m.p.: 203°C. 1H NMR (500 MHz, (CD3)2SO) δ/ppm = 12.29 (s, 1H, NH), 8.56 (d, J = 9.0 Hz, 1H, 6’-H), 7.68 (d, J = 2.5 Hz, 1H, 3’-H), 7.63 (t, J = 1.9 Hz, 1H, 4’’-H), 7.58 (d, J = 1.9 Hz, 2H, 2’’-H, 6’’-H), 7.36 (dd, J = 9.0, 2.5 Hz, 1H, 5’-H). 13C NMR (126 MHz, (CD3)2SO) δ/ppm = 182.7 (C-3), 166.4 (C-1), 145.2 (C-1’’), 137.8 (C-1’), 133.4 (C-3’’, C-5’’), 131.4 (C-6’), 128.4 (C-4’’), 127.8 (C-5’), 126.1 (C-2’’, C-6’’), 125.4 (C-4’), 123.5 (C-2), 122.1 (C-3’), 112.1 (C-2’), 77.3 (CN). IR (ATR) V~max/cm−1=3366, 3087, 2208, 1556, 1521, 1469, 1360, 1292, 863, 815. HRMS (ESI): calcd. for C16H779Br35Cl3N2O2 (M-H)- 442.87620; found 442.87736. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 60\n\nAccording to general procedure B, amide 17 (220 mg, 1.00 mmol, 1.0 eq.) in dry THF (10 mL), NaH (92.0 mg, 2.30 mmol, 2.3 eq.) and 3,5-dichlorobenzoyl chloride (230 mg, 1.10 mmol, 1.1 eq.) were used to give SGA-28 as yellow solid (200 mg, 0.508 mmol, 51%). Rf = 0.17 (3:2 hexanes/acetone). m.p.: 195°C. 1H NMR (500 MHz, (CD3)2SO) δ/ppm = 11.52 (s, 1H, NH), 7.68 (t, J = 1.8 Hz, 1H, 4’’-H), 7.62 (d, J = 1.8 Hz, 2H, 2’’-H, 6’’-H), 7.30 (d, J = 2.2 Hz, 1H, 2’-H), 7.01 (dd, J = 8.7, 2.2 Hz, 1H, 6’-H), 6.86 (d, J = 8.7 Hz, 1H, 5’-H), 3.73 (s, 3H, OCH3), 3.71 (s, 3H, OCH3). 13C NMR (126 MHz, (CD3)2SO) δ/ppm = 181.7 (C-3), 166.2 (C-1), 148.6 (C-3’), 144.4 (C-4’), 143.6 (C-1’’), 133.6 (C-3’’, C-5’’), 133.0 (C-1’), 128.9 (C-4’’), 126.2 (C-2’’, C-6’’), 122.2 (C-2), 112.3 (C-5’), 111.5 (C-6’), 104.9 (C-2’), 77.9 (CN), 55.8 (OCH3), 55.4 (OCH3). IR (ATR) V~max/cm−1=3284, 2217, 1608, 1549, 1516, 1238, 1028, 810. HRMS (ESI): calcd. for C18H1335Cl2N2O4 (M-H)- 391.02579; found 391.02608. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 61\n\nAccording to general procedure B, amide 15 (286 mg, 1.00 mmol, 1.0 eq.) in dry THF (10 mL), NaH (92.0 mg, 2.30 mmol, 2.3 eq.) and 3,5-dichlorobenzoyl chloride (230 mg, 1.10 mmol, 1.1 eq.) were used to give SGA-39 as yellow solid (237 mg, 0.515 mmol, 52%). Rf = 0.20 (3:2 hexanes/acetone). m.p.: 171°C. 1H NMR (400 MHz, (CD3)2SO) δ/ppm = 11.87 (s, 1H, NH), 8.27 (dd, J = 8.3, 1.5 Hz, 1H, 6’-H), 7.80 (dd, J = 7.9, 1.5 Hz, 1H, 3’-H), 7.63 (t, J = 1.9 Hz, 1H, 4’’-H), 7.59 (d, J = 1.9 Hz, 2H, 2’’-H, 6’’-H), 7.29 (ddd, J = 8.4, 7.3, 1.5 Hz, 1H, 5’-H), 6.80–6.67 (m, 1H, 4’-H). 13C NMR (126 MHz, (CD3)2SO) δ/ppm = 182.2 (C-3), 166.4 (C-1), 145.1 (C-1’’), 141.5 (C-1’), 139.0 (C-3’), 133.4 (C-3’’, C-5’’), 128.4 (C-4’’), 128.3 (C-5’), 126.1 (C-2’’, C-6’’), 124.0 (C-4’), 123.6 (C-2), 122.1 (C-6’), 89.2 (C-2’), 77.2 (CN). IR (ATR) V~max/cm−1=3337, 2213, 1579, 1537, 1294, 742. HRMS (ESI): calcd. for C16H835Cl2IN2O2 (M-H)- 456.90130; found 456.90095. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 62\n\nAccording to general procedure B, amide 16 (231 mg, 1.00 mmol, 1.0 eq.) in dry THF (10 mL), NaH (92.0 mg, 2.30 mmol, 2.3 eq.) and 3,5-dichlorobenzoyl chloride (230 mg, 1.10 mmol, 1.1 eq.) were used to give SGA-33 as colorless crystals (290 mg, 0.719 mmol, 72%). Rf = 0.15 (3:2 hexanes/acetone). m.p.: 193°C. 1H NMR (400 MHz, (CD3)2SO) δ/ppm = 12.34 (s, 1H, NH), 8.43 (td, J = 9.0, 6.0 Hz, 1H, 6’-H), 7.63 (t, J = 1.9 Hz, 1H, 4’’-H), 7.58 (d, J = 1.9 Hz, 2H, 2’’-H, 6’’-H), 7.23 (td, J = 9.2, 2.1 Hz, 1H, 5’-H). 13C NMR (101 MHz, (CD3)2SO) δ/ppm = 182.9 (C-3), 166.3 (C-1), 152.1 (d, JCF = 242.4 Hz, C-4’), 147.7 (d, JCF = 245.4 Hz, C-2’), 145.0 (C-1’’), 133.4 (C-3’’, C-5’’), 128.5 (C-4’’), 126.3 (dd, JCF = 10.3, 2.6 Hz, C-1’), 126.1 (C-2’’, C-6’’), 123.2 (C-2), 119.1 (dd, JCF = 7.8, 3.0 Hz, C-6’), 111.5 (dd, JCF = 20.7, 3.6 Hz, C-5’), 107.8 (dd, JCF = 22.2, 2.9 Hz, C-3’), 77.3 (CN). IR (ATR) V~max/cm−1=3293, 2206, 1539, 1497, 1370, 1289, 1023, 803. HRMS (ESI): calcd. for C16H635Cl3F2N2O2 (M-H)- 400.94684; found 400.94724. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 63\n\nAccording to general procedure B, amide 16 (231 mg, 1.00 mmol, 1.0 eq.) in dry THF (10 mL), NaH (92.0 mg, 2.30 mmol, 2.3 eq.) and 2,4,6-trichlorobenzoyl chloride (172 µL, 1.10 mmol, 1.1 eq.) were used to give SGA-73 as colorless solid (217 mg, 0.496 mmol, 50%). Rf = 0.16 (1:1 hexanes/acetone). m.p.: 199°C. 1H NMR (500 MHz, (CD3)2SO) δ/ppm = 11.93 (s, 1H, NH), 8.45 (td, J = 9.1, 5.9 Hz, 1H, 6’-H), 7.66 (s, 2H, 3’’-H, 5’’-H), 7.23 (td, J = 9.2, 2.0 Hz, 1H, 5’-H). 13C NMR (126 MHz, (CD3)2SO) δ/ppm = 180.8 (C-3), 165.6 (C-1), 152.1 (d, JCF = 242.6 Hz, C-4’), 147.5 (d, JCF = 245.6 Hz, C-2’), 139.4 (C-1’’ or C-4’’), 133.1 (C-1’’ or C-4’’), 132.0 (C-2’’, C-6’’), 127.8 (C-3’’, C-5’’), 126.3 (dd, JCF = 10.2, 3.2 Hz, C-1’), 121.8 (C-2), 118.8 (dd, JCF = 7.9, 2.9 Hz, C-6’), 111.5 (dd, JCF = 20.7, 3.5 Hz, C-5’), 107.9 (dd, JCF = 22.0, 19.2 Hz, C-3’), 79.4 (CN). IR (ATR) V~max/cm−1=3279, 2222, 1626, 1590, 1519, 1484, 1445, 1359, 1275, 1017, 816, 631. HRMS (ESI): calcd. for C16H535Cl4F2N2O2 (M-H)- 434.90787; found 434.90791. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 64\n\nAccording to general procedure B, amide 16 (231 mg, 1.00 mmol, 1.0 eq.) in dry THF (10 mL), NaH (92.0 mg, 2.30 mmol, 2.3 eq.) and 3,5-dibromobenzoic acid (308 mg, 1.10 mmol, 1.1 eq.; converted into the corresponding aryl chloride) were used to give SGA-90 as light yellow solid (374 mg, 0.759 mmol, 76%). Rf = 0.16 (1:1 hexanes/acetone). m.p.: 192°C. 1H NMR (400 MHz, (CD3)2SO) δ/ppm = 12.33 (s, 1H, NH), 8.43 (td, J = 8.9, 6.0 Hz, 1H, 6’-H), 7.86 (t, J = 1.7 Hz, 1H, 4’’-H), 7.74 (d, J = 1.7 Hz, 2H, 2’’-H, 6’’-H), 7.23 (td, J = 9.3, 2.0 Hz, 1H, 5’-H). 13C NMR (101 MHz, (CD3)2SO) δ/ppm = 182.7 (C-3), 166.3 (C-1), 152.1 (d, JCF = 242.4 Hz, C-2’), 147.7 (d, JCF = 242.4 Hz, C-4’), 145.4 (C-1’’), 133.7 (C-4’’), 129.2 (C-2’’, C-6’’), 126.3 (dd, JCF = 10.3, 3.2 Hz, C-1’), 123.2 (C-2), 121.8 (C-3’’, C-5’’), 119.1 (dd, JCF = 7.5, 2.9 Hz, C-6’), 111.5 (dd, JCF = 20.7, 3.6 Hz, C-5’), 108.3–107.7 (m, C-3’), 77.3 (CN). IR (ATR) V~max/cm−1=3297, 2205, 1586, 1531, 1496, 1022, 803, 750. HRMS (ESI): calcd. for C16H679Br2ClF2N2O2 (M-H)- 488.84581; found 488.84607. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 65\n\nAccording to general procedure B, amide 18 (229 mg, 1.00 mmol, 1.0 eq.) in dry THF (10 mL), NaH (92.0 mg, 2.30 mmol, 2.3 eq.) and 3,5-dichlorobenzoyl chloride (230 mg, 1.10 mmol, 1.1 eq.) were used to give SGA-78 as colorless crystals (344 mg, 0.856 mmol, 86%). Rf = 0.17 (3:2 hexanes/acetone). m.p.: 211°C. 1H NMR (400 MHz, (CD3)2SO) δ/ppm = 12.49 (s, 1H, NH), 8.58 (dd, J = 8.3, 1.5 Hz, 1H, 6’-H), 7.63 (t, J = 1.9 Hz, 1H, 4’’-H), 7.59 (d, J = 1.9 Hz, 2H, 2’’-H, 6’’-H), 7.27 (t, J = 8.2 Hz, 1H, 5’-H), 7.20 (dd, J = 8.0, 1.5 Hz, 1H, 4’-H). 13C NMR (126 MHz, (CD3)2SO) δ/ppm = 182.8 (C-3), 166.4 (C-1), 145.1 (C-1’’), 139.3 (C-1’), 133.4 (C-3’’, C-5’’), 131.4 (C-3’), 128.5 (C-4’’), 128.0 (C-5’), 126.1 (C-2’’, C-6’’), 123.4 (C-2), 122.6 (C-4’), 119.3 (C-2’), 119.1 (C-6’), 77.5 (CN). IR (ATR) V~max/cm−1=3355, 2203, 1649, 1584, 1539, 1453, 1415, 872, 812, 777. HRMS (ESI): calcd. for C16H735Cl4N2O2 (M-H)- 398.92671; found 398.92789. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 66\n\nAccording to general procedure B, amide 19 (318 mg, 1.00 mmol, 1.0 eq.) in dry THF (10 mL), NaH (92.0 mg, 2.30 mmol, 2.3 eq.) and 3,5-dichlorobenzoyl chloride (230 mg, 1.10 mmol, 1.1 eq.) were used to give SGA-77 as colorless crystals (66.0 mg, 0.134 mmol, 13%). Rf = 0.78 (3:2 hexanes/acetone). m.p.: 226°C. 1H NMR (400 MHz, (CD3)2SO) δ/ppm = 10.64 (s, 1H, NH), 8.09–7.90 (m, 3H, 2’’-H, 6’’-H, 4’’-H), 7.79 (d, J = 8.0 Hz, 2H, 3’-H, 5’-H), 7.26 (t, J = 8.0 Hz, 1H, 4’-H). 13C NMR (101 MHz, (CD3)2SO) δ/ppm = 162.4 (C-1, C-3), 136.6 (C-1’’), 135.2 (C-1’), 134.6 (C-3’’, C-5’’), 132.3 (C-3’, C-5’), 131.5 (C-4’’), 130.7 (C-4’), 126.4 (C-2’’, C-6’’), 124.4 (C-2’, C-6’), 76.4 (CN), C-2 is missing. IR (ATR) V~max/cm−1=3206, 2215, 1650.1567, 1516, 1283, 779, 750, 723. HRMS (ESI): calcd. for C16H779Br235Cl2N2O2 (M-H)- 486.82568; found 486.82870. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 67\n\nAccording to general procedure B, amide 20 (296 mg, 1.00 mmol, 1.0 eq.) in dry THF (10 mL), NaH (92.0 mg, 2.30 mmol, 2.3 eq.) and 3,5-dichlorobenzoyl chloride (230 mg, 1.10 mmol, 1.1 eq.) were used to give SGA-85 as colorless solid (320 mg, 0.682 mmol, 68%). Rf = 0.15 (3:2 hexanes/acetone). m.p.: 210°C. 1H NMR (400 MHz, (CD3)2SO) δ/ppm = 12.58 (s, 1H, NH), 8.93 (s, 1H, OH), 8.25 (s, 2H, 2’-H, 6’-H), 7.65 (t, J = 1.9 Hz, 1H, 4’’-H), 7.62–7.56 (m, 3H, 4’-H, 2’’-H, 6’’-H). 13C NMR (101 MHz, (CD3)2SO) δ/ppm = 183.5 (C-3), 167.3 (C-1), 145.4 (C-1’’), 142.3 (C-1’), 134.0 (C-3’’, C-5’’), 131.2 (q, JCF = 32.6 Hz, C-3’, C-5’), 129.1 (C-4’’), 126.5 (C-2’’, C-6’’), 123.7 (q, JCF = 270.8 Hz, CF3), 123.4 (C-2), 119.1–118.8 (m, C-2’, C-6’), 114.8–114.5 (m, C-4’), 77.6 (CN). IR (ATR) V~max/cm−1=2230, 1637, 1571, 1547, 1375, 1275, 1175, 1128, 810. HRMS (ESI): calcd. for C18H735Cl2F6N2O2 (M-H)- 466.97943; found 466.97933. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 68\n\nAccording to general procedure B, amide 21 (242 mg, 1.00 mmol, 1.0 eq.) in dry THF (10 mL), NaH (92.0 mg, 2.30 mmol, 2.3 eq.) and 3,5-dichlorobenzoyl chloride (230 mg, 1.10 mmol, 1.1 eq.) were used to give SGA-115 as colorless solid (198 mg, 0.476 mmol, 48%). Rf = 0.67 (3:2 hexanes/acetone). m.p.: 147°C. 1H NMR (400 MHz, CDCl3) δ/ppm = 7.80–7.73 (m, 2H, 3’-H, 5’-H), 7.64 (d, J = 1.9 Hz, 2H, 2’’-H, 6’’-H), 7.49 (t, J = 1.9 Hz, 1H, 4’’-H), 7.47–7.41 (m, 2H, 2’-H, 6’-H), 3.48 (s, 3H, CH3). 13C NMR (101 MHz, CDCl3) δ/ppm = 184.2 (C-3), 170.4 (C-1), 145.2 (C-1’), 135.8 (C-1’’), 135.5 (C-3’’, C-5’’), 132.5 (C-4’’), 131.4 (q, JCF = 32.9 Hz, C-4’), 127.8 (C-2’, C-6’), 127.5 (q, J = 3.6 Hz, C-3’, C-5’), 127.2 (C-2’’, C-6’’), 123.7 (q, JCF = 272.6 Hz, CF3), 115.3 (C-2), 78.6 (CN), 39.9 (CH3). IR (ATR) V~max/cm−1=3074, 2214, 1578, 1540, 1396, 1331, 1165, 1118, 807. HRMS (ESI): calcd. for C18H1035Cl2F3N2O2 (M-H)- 413.00769; found 413.00806. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 69\n\nAccording to general procedure B, amide 22 (242 mg, 1.00 mmol, 1.0 eq.) in dry THF (10 mL), NaH (92.0 mg, 2.30 mmol, 2.3 eq.) and 3,5-dichlorobenzoyl chloride (230 mg, 1.10 mmol, 1.1 eq.) were used to give SGA-138 as colorless solid (228 mg, 0.549 mmol, 55%). Rf = 0.70 (3:2 hexanes/acetone). m.p.: 173°C. 1H NMR (500 MHz, (CD3)2SO) δ/ppm = 9.57 (s, 1H, NH), 7.84 (t, J = 1.8 Hz, 1H, 4’’-H), 7.77 (d, J = 1.8 Hz, 2H, 2’’-H, 6’’-H), 7.74–7.69 (m, 2H, 3’-H, 5’-H), 7.57–7.50 (m, 2H, 2’-H, 6’-H), 4.52 (s, 2H, CH2). 13C NMR (126 MHz, (CD3)2SO) δ/ppm = 181.1 (C-3), 169.2 (C-1), 143.5 (C-1’), 138.5 (C-1’’), 134.2 (C-3’’, C-5’’), 130.8 (C-4’’), 128.1 (C-2’, C-6’), 127.7 (q, JCF = 31.7 Hz, C-4’), 126.6 (C-2’’, C-6’’), 125.3 (q, JCF = 3.8 Hz, C-3’, C-5’), 124.3 (q, JCF = 271.9 Hz, CF3), 118.1 (C-2), 78.0 (CN), 42.4 (CH2). IR (ATR) V~max/cm−1=3326, 2206, 1538, 1324, 1108, 1067, 805. HRMS (ESI): calcd. for C18H1035Cl2F3N2O2 (M-H)- 413.00769; found 413.00780. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 70\n\n4-Bromo-2-iodo-1-(trifluoromethoxy)benzene (610 mg, 1.66 mmol, 1.0 eq.) was dissolved in dry THF (8.0 mL) and cooled to −78°C, then n-BuLi (0.670 mL, 1.66 mmol, 1.0 eq.) was added dropwise. The mixture was stirred for 20 min at −78°C and a solution of 2-chloro-N-methoxy-N-methylacetamide (700 mg, 4.99 mmol, 3.0 eq.) in dry THF (8.0 mL) was added slowly. The mixture was stirred for 1 hr at −78°C and then poured on sat. aq. NH4Cl solution. The mixture was extracted with pentane, the organic layer was washed with sat. aq. NaCl solution, dried using hydrophobic phase separation filter papers and filtered through a short silica column (eluent: pentane). The product was carefully concentrated under ambient pressure to yield a colorless oil (23, 221 mg, 0.696 mmol, 42%). Rf = 0.65 (9:1 hexanes/EtOAc). 1H NMR (500 MHz, CDCl3) δ/ppm = 7.93 (d, J = 2.5 Hz, 1H, 6’-H), 7.71 (dd, J = 8.8, 2.5 Hz, 1H, 4’-H), 7.25–7.22 (m, 1H, 3’-H), 4.61 (s, 2H, 2 hr). 13C NMR (126 MHz, CDCl3) δ/ppm = 190.5 (C-1), 146.2 (C-2’), 137.1 (C-4’), 134.1 (C-6’), 130.8 (C-5’), 122.2 (C-3’), 120.8 (C-1’), 120.3 (q, JCF = 261 Hz, OCF3), 49.0 (C-2). IR (ATR) V~max/cm−1=1703, 1592, 1480, 1398, 1308, 1252, 1174, 1129, 1088, 822, 664. HRMS (EI): calcd. for C9H579Br35ClF3O2 (M)˙+ 315.9108; found 315.9106. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 71\n\n2'-(Trifluoromethoxy)acetophenone (779 µL, 4.90 mmol, 1.0 eq.) was dissolved in CH2Cl2 (10 mL), then p-toluenesulfonic acid (86.1 mg, 0.490 mmol, 0.10 eq.) and N-bromosuccinimide (872 mg, 4.90 mmol, 1.0 eq.) were added. The mixture was stirred for 24 hr at rt, then sat. aq. NaCl (10 mL) was added. The aqueous phase was extracted with CH2Cl2 (3 × 10 mL), dried using a hydrophobic filter paper and concentrated in vacuo. Purification by FCC (pentane/EtOAc 9:1) yielded bromoketone 24 (672 mg, 2.87 mmol, 49%) as light brown liquid. Analytical data are in accordance with literature (Saruta et al., 2015). Rf = 0.58 (9:1 hexanes/EtOAc). 1H NMR (400 MHz, CDCl3) δ/ppm = 7.81 (dd, J = 7.8, 1.8 Hz, 1H, 6’-H), 7.60 (ddd, J = 8.3, 7.6, 1.8 Hz, 1H, 4’-H), 7.41 (td, J = 7.6, 1.0 Hz, 1H, 5’-H), 7.37–7.32 (m, 1H, 3’-H), 4.47 (s, 2H, 2 hr). 13C NMR (101 MHz, CDCl3) δ/ppm = 191.5 (C-1), 147.1 (q, J = 1.7 Hz, C-2’), 134.3 (C-4’), 131.6 (C-6’), 129.3 (C-1’), 127.3 (C-5’), 120.6 (C-3’), 120.5 (q, J = 260.1 Hz, OCF3), 35.1 (C-2). IR (ATR) V~max/cm−1=1698, 1603, 1450, 1295, 1248, 1200, 1160. HRMS (EI): calcd. for C9H679BrF3O2 (M)˙+ 281.9498; found 281.9494. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 72\n\nFollowing general procedure C, ethyl acetoacetate (88.0 µL, 0.693 mmol, 1.1 eq.) in dry THF (3.0 mL), NaH (37.8 mg, 0.945 mmol, 1.5 eq.) and a solution of ketone 23 (200 mg, 0.630 mmol, 1.0 eq.) and KI (209 mg, 1.26 mmol, 2.0 eq.) in dry THF (3.0 mL) were used. Then the residue was dissolved in acetic acid (6.0 mL) and cyclohexanemethanamine (0.160 mL, 1.26 mmol, 2.0 eq.) was added. FCC (hexanes/EtOAc 99:1) yielded SGA-140 as colorless oil (140 mg, 0.287 mmol, 46%). Rf = 0.30 (9:1 hexanes/EtOAc). 1H NMR (400 MHz, CDCl3) δ/ppm = 7.54–7.50 (m, 2H, 4’-H, 6’-H), 7.20 (ddt, J = 7.6, 3.0, 1.5 Hz, 1H, 3’-H), 6.55 (s, 1H, 4 hr), 4.27 (q, J = 7.1 Hz, 2H, CH2CH3), 3.59 (d, J = 7.1 Hz, 2H, CH2-cy), 2.59 (s, 3H, CH3), 1.60–1.54 (m, 3H, cy), 1.38–1.32 (m, 6H, CH2CH3, cy), 1.07–0.99 (m, 3H, cy), 0.68–0.59 (m, 2H, cy). 13C NMR (121 MHz, CDCl3) δ/ppm = 165.6 (COOEt), 146.3 (C-2’), 137.6 (C-3), 135.7 (C-6’), 132.4 (C-4’), 129.0 (C-5’), 126.5 (C-5), 122.1 (C-3’), 120.3 (q, JCF = 260.2 Hz, OCF3), 119.9 (C-1’), 112.6 (C-2), 112.2 (C-4), 59.6 (CH2CH3), 50.8 (CH2-cy), 39.0 (cy), 30.6 (cy), 26.2 (cy), 25.7 (cy), 14.7 (CH2CH3), 12.1 (CH3). IR (ATR) V~max/cm−1=2976, 2925, 2854, 1699, 1254, 1240, 1206, 1190, 1169, 1080, 1064, 774. HRMS (ESI): calcd. for C22H2679BrF3NO3 (M+H)+ 488.10427; found 488.10459. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 73\n\nAccording to general procedure D, LiOH (51.6 mg, 2.05 mmol, 10 eq.) and a solution of SGA-140 (100 mg, 0.205 mmol, 1.0 eq.) in dioxane/H2O (3.0 mL) were used. After 2 hr the reaction was completed and recrystallization from EtOH gave TPC2-A1-P as a colorless solid (51.2 mg, 0.111 mmol, 54%). Rf = 0.14 (9:1 hexanes/EtOAc). m.p.: 202°C. 1H NMR (500 MHz, CDCl3) δ/ppm = 11.34 (s, 1H, COOH), 7.56–7.51 (m, 2H, 3’-H, 4’-H), 7.23–7.19 (m, 1H, 6’-H), 6.61 (s, 1H, 4 hr), 3.60 (d, J = 7.1 Hz, 2H, CH2-cy), 2.60 (s, 3H, CH3), 1.62–1.56 (m, 3H, cy), 1.40–1.33 (m, 3H, cy), 1.09–1.01 (m, 3H, cy), 0.68–0.61 (m, 2H, cy). 13C NMR (126 MHz, CDCl3) δ/ppm = 170.0 (COOH), 146.4 (C-2’), 138.8 (C-2), 135.7 (C-6’), 132.6 (C-4’), 128.8 (C-5’), 126.8 (C-5), 122.2 (C-3’), 120.3 (q, JCF = 259.3 Hz, OCF3), 119.9 (C-1’), 112.9 (C-4), 111.6 (C-3), 50.9 (CH2-cy), 39.0 (cy), 30.6 (cy), 26.2 (cy), 25.7 (cy), 12.3 (CH3). IR (ATR) V~max/cm−1=2961, 2924, 2875, 2853, 2359, 2342, 1667, 1266, 1243, 1212, 1198, 1171, 925, 779, 658. HRMS (ESI): calcd. for C20H2079BrF3NO3 (M-H)- 458.05841; found 458.05889. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 74\n\nFollowing general procedure C, ethyl acetoacetate (42.0 µL, 3.30 mmol, 1.1 eq.) in dry THF (12 mL), NaH (180 mg, 4.50 mmol, 1.5 eq.) and a solution of 2-bromo-1-phenylethan-1-one (405 µL, 3.00 mmol, 1.0 eq.) and KI (996 mg, 6.00 mmol, 2.0 eq.) in dry THF (10 mL) were used. Then the residue was dissolved in acetic acid (10 mL) and cyclohexanemethanamine (781 µL, 6.00 mmol, 2.0 eq.) was added. FCC (hexanes/EtOAc 9:1) yielded SGA-43 as colorless solid (516 mg, 1.58 mmol, 53%). The compound is literature known, but no analytical data are available (Kang et al., 2010). Rf = 0.49 (9:1 hexanes/EtOAc). m.p.: 91°C. 1H NMR (400 MHz, CDCl3) δ/ppm = 7.42–7.36 (m, 2H, Ph), 7.35–7.29 (m, 3H, Ph), 6.53 (s, 1H, 4 hr), 4.27 (q, J = 7.1 Hz, 2H, CH2CH3), 3.78 (d, J = 7.1 Hz, 2H, CH2-cy), 2.60 (s, 3H, CH3), 1.58–1.49 (m, 3H, cy), 1.41–1.31 (m, 6H, cy, CH2CH3), 1.06–0.95 (m, 3H, cy), 0.69–0.57 (m, 2H, cy). 13C NMR (121 MHz, CDCl3) δ/ppm = 165.9 (COOEt), 137.0 (C-2), 134.1 (qPh), 133.7 (C-5), 129.6 (Ph), 128.5 (Ph), 127.4 (Ph), 112.0 (C-3), 110.0 (C-4), 59.4 (CH2CH3), 50.2 (CH2-cy), 39.0 (cy), 30.6 (cy), 26.2 (cy), 25.8 (cy), 14.7 (CH2CH3), 12.1 (CH3). IR (ATR) V~max/cm−1=2975, 2926, 2850, 1738, 1698, 1420, 1242, 1224, 1191, 1062, 772, 702. HRMS (ESI): calcd. for C21H28NO2 (M+H)+ 326.21146; found 326.21121. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 75\n\nAccording to general procedure D, LiOH (38.7 mg, 1.54 mmol, 10 eq.) and a solution of SGA-43 (50.0 mg, 0.154 mmol, 1.0 eq.) in dioxane/H2O (1.3 mL) were used. After 1 hr the reaction was completed and gave SGA-53 as a colorless solid (40.4 mg, 0.136 mmol, 88%). The compound is literature known, but no analytical data are available (Kang et al., 2010). Rf = 0.18 (6:1 hexanes/EtOAc). m.p.: 196°C. 1H NMR (500 MHz, CDCl3) δ/ppm = 7.42–7.38 (m, 2H, Ph), 7.36–7.32 (m, 3H, Ph), 6.59 (s, 1H, 4 hr), 3.80 (d, J = 7.2 Hz, 2H, CH2), 2.62 (s, 3H, CH3), 1.59–1.52 (m, 3H, cy), 1.42–1.33 (m, 3H, cy), 1.06–0.97 (m, 3H, cy), 0.68–0.59 (m, 2H, cy). 13C NMR (101 MHz, CDCl3) δ/ppm = 170.8 (COOH), 138.3 (C-2), 134.5 (C-5), 133.5 (qPh), 129.7 (Ph), 128.5 (Ph), 127.5 (Ph), 111.2 (C-3), 110.7 (C-4), 50.3 (CH2), 39.0 (cy), 30.6 (cy), 26.2 (cy), 25.8 (cy), 12.3 (CH3). IR (ATR) V~max/cm−1=3030, 2971, 2921, 2848, 1738, 1660, 1533, 1435, 1364, 1267, 1227, 1205, 778, 768, 712, 703. HRMS (ESI): calcd. for C19H22NO2 (M-H)- 296.16572; found 296.16560. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 76\n\nFollowing general procedure C, ethyl acetoacetate (143 µL, 1.10 mmol, 1.1 eq.) in dry THF (5.0 mL), NaH (60.0 mg, 1.50 mmol, 1.5 eq.) and a solution of 2-bromo-1-(5-bromo-2-methoxyphenyl)ethan-1-one (308 mg, 1.00 mmol, 1.0 eq.) in dry THF (1.0 mL) were used. Then the residue was dissolved in acetic acid (5.0 mL) and cyclohexanemethanamine (0.260 mL, 2.00 mmol, 2.0 eq.) was added. FCC (hexanes/EtOAc 9:1) yielded SGA-54 as colorless solid (411 mg, 0.947 mmol, 95%). Rf = 0.37 (6:1 hexanes/EtOAc). m.p.: 83°C. 1H NMR (400 MHz, CDCl3) δ/ppm = 7.45 (dd, J = 8.7, 2.5 Hz, 1H, 4’-H), 7.37 (d, J = 2.5 Hz, 1H, 6’-H), 6.81 (d, J = 8.7 Hz, 1H, 3’-H), 6.48 (s, 1H, 4 hr), 4.25 (q, J = 7.1 Hz, 2H, CH2CH3), 3.76 (s, 3H, OCH3), 3.56 (d, J = 7.2 Hz, 2H, CH2-cy), 2.58 (s, 3H, CH3), 1.60–1.54 (m, 3H, cy), 1.41–1.29 (m, 6H, cy, CH2CH3), 1.08–0.97 (m, 3H, cy), 0.68–0.57 (m, 2H, cy). 13C NMR (101 MHz, CDCl3) δ/ppm = 165.7 (COOEt), 156.6 (C-2’), 136.9 (C-2), 135.2 (C-6’), 132.3 (C-4’), 128.9 (C-5), 124.8 (C-1’), 112.8 (C-5’), 112.6 (C-3’), 112.1 (C-3), 110.6 (C-4), 59.3 (CH2CH3), 55.9 (OCH3), 50.9 (CH2-cy), 39.0 (cy), 30.7 (cy), 26.3 (cy), 25.8 (cy), 14.7 (CH2CH3), 12.1 (CH3). IR (ATR) V~max/cm−1=2979, 2928, 2849, 1695, 1676, 1473, 1461, 1434, 1253, 1234, 1187, 1176, 1060, 1048, 1027, 774, 619. HRMS (ESI): calculated for C22H2979BrNO3 (M+H)+ 434.13253; found 434.13229. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 77\n\nAccording to general procedure D, LiOH (88.4 mg, 3.51 mmol, 10 eq.) and a solution of SGA-54 (152 mg, 0.351 mmol, 1.0 eq.) in dioxane/H2O (1.3 mL) were used. After 1 hr the reaction was completed and gave SGA-55 as a colorless solid (90.0 mg, 0.222 mmol, 63%). Rf = 0.72 (1:1 hexanes/EtOAc). m.p.: 224°C. 1H NMR (400 MHz, CDCl3) δ/ppm = 7.46 (dd, J = 8.8, 2.5 Hz, 1H, 4’-H), 7.38 (d, J = 2.5 Hz, 1H, 6’-H), 6.82 (d, J = 8.8 Hz, 1H, 3’-H), 6.54 (s, 1H, 4 hr), 3.77 (s, 3H, OCH3), 3.57 (d, J = 7.2 Hz, 2H, CH2-cy), 2.59 (s, 3H, CH3), 1.62–1.52 (m, 3H, cy), 1.43–1.33 (m, 3H, cy), 1.10–0.98 (m, 3H, cy), 0.69–0.58 (m, 2H, cy). 13C NMR (101 MHz, CDCl3) δ/ppm = 170.4 (COOH), 156.6 (C-2’), 138.2 (C-2), 135.2 (C-6’), 132.4 (C-4’), 129.3 (C-5), 124.6 (C-1’), 112.8 (C-5’), 112.6 (C-3’), 111.4 (C-4), 111.3 (C-3), 55.9 (OCH3), 51.0 (CH2-cy), 39.0 (cy), 30.7 (cy), 26.3 (cy), 25.8 (cy), 12.3 (CH3). IR (ATR) V~max/cm−1=3027, 2969, 2926, 2850, 1739, 1658, 1476, 1462, 1442, 1362, 1274, 1244, 1205, 1018, 808, 782, 619. HRMS (ESI): calculated for C20H2379BrNO3 (M-H)- 404.08668; found 404.08697. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 78\n\nFollowing general procedure C, ethyl acetoacetate (208 µL, 1.65 mmol, 1.1 eq.) in dry THF (5.0 mL), NaH (90.0 mg, 2.25 mmol, 1.5 eq.) and a solution of 2-bromo-1-(2,5-dichlorophenyl)ethan-1-one (402 mg, 1.50 mmol, 1.0 eq.) in dry THF (1.0 mL) were used. Then the residue was dissolved in acetic acid (5.0 mL) and cyclohexanemethanamine (390 µL, 3.00 mmol, 2.0 eq.) was added. FCC (hexanes/EtOAc 9:1), followed by recrystallization from EtOH yielded SGA-48 as colorless solid (271 mg, 0.686 mmol, 46%). Rf = 0.48 (9:1 hexanes/EtOAc). m.p.: 98°C. 1H NMR (400 MHz, CDCl3) δ/ppm = 7.48 (d, J = 2.0 Hz, 1H, 6’-H), 7.29 (dd, J = 8.2, 2.0 Hz, 1H, 4’-H), 7.25 (d, J = 9.1 Hz, 1H, 3’-H, collapses with chloroform), 6.51 (s, 1H, 4 hr), 4.27 (q, J = 7.0 Hz, 2H, CH2CH3), 3.55 (d, J = 7.0 Hz, 2H, CH2-cy), 2.59 (s, 3H, CH3), 1.61–1.56 (m, 3H, cy), 1.40–1.31 (m, 6H, cy, CH2CH3), 1.08–0.99 (m, 3H, cy), 0.68–0.58 (m, 2H, cy). 13C NMR (101 MHz, CDCl3) δ/ppm = 165.6 (COOEt), 137.0 (C-2), 135.9 (C-1’ or C-5’), 134.8 (C-1’ or C-5’), 134.0 (C-3’), 131.2 (C-2’), 129.6 (C-6’), 129.2 (C-5), 127.2 (C-4’), 112.2 (C-3), 111.1 (C-4), 59.5 (CH2CH3), 50.8 (CH2-cy), 39.1 (cy), 30.6 (cy), 26.2 (cy), 25.8 (cy), 14.7 (CH2CH3), 12.1 (CH3). IR (ATR) V~max/cm−1=2981, 2923, 2845, 1739, 1723, 1695, 1565, 1454, 1262, 1238, 1201, 1159, 1076, 1066, 800, 771. HRMS (ESI): calculated for C21H2635Cl2NO2 (M+H)+ 394.13351; found 394.13343. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 79\n\nAccording to general procedure D, LiOH (63.9 mg, 2.54 mmol, 10 eq.) and a solution of SGA-48 (100 mg, 0.254 mmol, 1.0 eq.) in dioxane/H2O (1.3 mL) were used. After 1 hr the reaction was completed and gave SGA-52 as a colorless solid (75.7 mg, 0.207 mmol, 81%). Rf = 0.18 (6:1 hexanes/EtOAc). m.p.: 180°C. 1H NMR (500 MHz, CDCl3) δ/ppm = 7.48 (d, J = 2.0 Hz, 1H, 6’-H), 7.30 (dd, J = 8.2, 2.0 Hz, 1H, 4’-H), 7.26 (d, J = 8.2 Hz, 1H, 3’-H, collapses with chloroform), 6.57 (s, 1H, 4 hr), 3.57 (d, J = 6.4 Hz, 2H, CH2-cy), 2.60 (s, 3H, CH3), 1.63–1.57 (m, 3H, cy), 1.42–1.36 (m, 3H, cy), 1.08–1.00 (m, 3H, cy), 0.68–0.59 (m, 2H, cy). 13C NMR (126 MHz, CDCl3) δ/ppm = 170.7 (COOH), 138.3 (C-2), 136.0 (C-1’ or C-5’), 135.0 (C-1’ or C-5’), 134.0 (C-3’), 131.0 (C-2’), 129.7 (C-6’), 129.6 (C-5), 127.2 (C-4’), 111.8 (C-4), 111.4 (C-3), 50.9 (CH2-cy), 39.0 (cy), 30.7 (cy), 26.2 (cy), 25.8 (cy), 12.3 (CH3). IR (ATR) V~max/cm−1=3014, 2970, 2926, 2851, 1739, 1659, 1449, 1365, 1270, 1228, 1217, 1204, 814, 776. HRMS (ESI): calculated for C19H2035Cl2NO2 (M-H)- 364.08766; found 364.08783. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 80\n\nFollowing general procedure C, ethyl acetoacetate (208 µL, 1.65 mmol, 1.1 eq.) in dry THF (5.0 mL), NaH (90.0 mg, 2.25 mmol, 1.5 eq.) and a solution of 2-chloro-1-(4-fluorophenyl)ethan-1-one (259 mg, 1.50 mmol, 1.0 eq.) and KI (249 mg, 1.50 mmol, 1.0 eq.) in dry THF (3.0 mL) were used. Then the residue was dissolved in acetic acid (5.0 mL) and cyclohexanemethanamine (0.390 mL, 3.00 mmol, 2.0 eq.) was added. FCC (hexanes/EtOAc 9:1) yielded SGA-59 as yellow oil (499 mg, 1.45 mmol, 97%). Rf = 0.43 (9:1 hexanes/EtOAc). 1H NMR (500 MHz, CDCl3) δ/ppm = 7.28–7.23 (m, 2H, 2’-H, 6’-H), 7.10–7.01 (m, 2H, 3’-H, 5’-H), 6.48 (s, 1H, 4 hr), 4.25 (q, J = 7.1 Hz, 2H, CH2CH3), 3.71 (d, J = 7.2 Hz, 2H, CH2-cy), 2.57 (s, 3H, CH3), 1.58–1.48 (m, 3H, cy), 1.38–1.28 (m, 6H, cy, CH2CH3), 1.06–0.89 (m, 3H, cy), 0.68–0.53 (m, 2H, cy). 13C NMR (121 MHz, CDCl3) δ/ppm = 165.7 (COOH), 162.2 (d, JCF = 247.0 Hz, C-4’), 136.9 (C-2), 132.8 (C-5), 131.3 (d, JCF = 8.0 Hz, C-2’, C-6’), 129.7 (d, JCF = 3.3 Hz, C-1’), 115.4 (d, JCF = 21.3 Hz, C-3’, C-5’), 111.9 (C-3), 110.0 (C-4), 59.3 (CH2CH3), 50.1 (CH2-cy), 39.0 (cy), 30.5 (cy), 26.1 (cy), 25.7 (cy), 14.6 (CH2CH3), 12.0 (CH3). IR (ATR) V~max/cm−1=2977, 2925, 2853, 1693, 1242, 1227, 1218, 1195, 1152, 1062, 844, 811, 774. HRMS (ESI): calculated for C21H27FNO2 (M+H)+ 344.20203; found 344.20193. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 81\n\nAccording to general procedure D, LiOH (169 mg, 6.71 mmol, 10 eq.) and a solution of SGA-59 (230 mg, 0.671 mmol, 1.0 eq.) in dioxane/H2O (3.0 mL) were used. After 2 hr the reaction was completed and gave SGA-66 as a colorless solid (186 mg, 0.590 mmol, 88%). Rf = 0.24 (6:1 hexanes/EtOAc). m.p.: 171°C. 1H NMR (400 MHz, CDCl3) δ/ppm = 7.35–7.27 (m, 2H, 2’-H, 6’-H), 7.14–7.04 (m, 2H, 3’-H, 5’-H), 6.57 (s, 1H, 4 hr), 3.75 (d, J = 7.1 Hz, 2H, CH2-cy), 2.61 (s, 3H, CH3), 1.63–1.51 (m, 3H, cy), 1.41–1.32 (m, 3H, cy), 1.08–0.97 (m, 3H, cy), 0.70–0.57 (m, 2H, cy). 13C NMR (121 MHz, CDCl3) δ/ppm = 171.2 (COOH), 162.37 (d, JCF = 247.1 Hz, C-4’), 138.3 (C-2), 133.3 (C-5), 131.42 (d, JCF = 8.1 Hz, C-2’, C-6’), 129.6 (d, JCF = 3.4 Hz, C-1’), 115.57 (d, JCF = 21.5 Hz, C-3’, C-5’), 111.2 (C-3), 110.8 (C-4), 50.3 (CH2-cy), 39.0 (cy), 30.6 (cy), 26.2 (cy), 25.8 (cy), 12.3 (CH3). IR (ATR) V~max/cm−1=2927, 2854, 1739, 1652, 1568, 1494, 1449, 1265, 1223, 1203, 1158, 840, 776, 582. HRMS (ESI): calculated for C19H21FNO2 (M-H)- 314.15618; found 314.15635. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 82\n\nFollowing general procedure C, ethyl acetoacetate (208 µL, 1.65 mmol, 1.1 eq.) in dry THF (5.0 mL), NaH (90.0 mg, 2.25 mmol, 1.5 eq.) and a solution of 2-bromo-1-(4-methoxyphenyl)ethan-1-one (344 mg, 1.50 mmol, 1.0 eq.) and KI (249 mg, 1.50 mmol, 1.0 eq.) in dry THF (3.0 mL) were used. Then the residue was dissolved in acetic acid (5.0 mL) and cyclohexanemethanamine (390 µL, 3.00 mmol, 2.0 eq.) was added. FCC (hexanes/EtOAc 9:1), followed by recrystallization from EtOH yielded SGA-61 as colorless solid (274 mg, 0.770 mmol, 51%). Rf = 0.37 (9:1 hexanes/EtOAc). m.p.: 88°C. 1H NMR (500 MHz, CDCl3) δ/ppm = 7.25–7.21 (m, 2H, 2’-H, 6’-H), 6.95–6.89 (m, 2H, 3’-H, 5’-H), 6.47 (s, 1H, 4 hr), 4.27 (q, J = 7.1 Hz, 2H, CH2CH3), 3.84 (s, 3H, OCH3), 3.73 (d, J = 7.3 Hz, 2H, CH2-cy), 2.58 (s, 3H, CH3), 1.60–1.51 (m, 3H, cy), 1.42–1.31 (m, 6H, cy, CH2CH3), 1.07–0.96 (m, 3H, cy), 0.70–0.59 (m, 2H, cy). 13C NMR (126 MHz, CDCl3) δ/ppm = 165.9 (COOH), 159.0 (C-4’), 136.6 (C-2), 133.8 (C-5), 130.9 (C-2’, C-6’), 126.1 (C-1’), 113.9 (C-3’, C-5’), 111.7 (C-3), 109.5 (C-4), 59.3 (CH2CH3), 55.4 (OCH3), 50.1 (CH2-cy), 39.0 (cy), 30.6 (cy), 26.2 (cy), 25.8 (cy), 14.7 (CH2CH3), 12.1 (CH3). IR (ATR) V~max/cm−1=3016, 2970, 2928, 2847, 1739, 1693, 1568, 1532, 1496, 1443, 1424, 1373, 1243, 1226, 1195, 1175, 1064, 1031, 835, 817, 795, 774. HRMS (ESI): calculated for C22H30NO3 (M+H)+ 356.22202; found 356.22192. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 83\n\nAccording to general procedure D, LiOH (78.7 mg, 3.12 mmol, 10 eq.) and a solution of SGA-61 (111 mg, 0.312 mmol, 1.0 eq.) in dioxane/H2O (1.3 mL) were used. After 2 hr the reaction was completed and gave SGA-67 as a colorless solid (95.3 mg, 0.291 mmol, 90%). Rf = 0.20 (6:1 hexanes/EtOAc). m.p.: 198°C. 1H NMR (400 MHz, CDCl3) δ/ppm = 7.27–7.23 (m, 2H, 2’-H, 6’-H), 6.95–6.91 (m, 2H, 3’-H, 5’-H), 6.54 (s, 1H, 4 hr), 3.85 (s, 3H, OCH3), 3.75 (d, J = 7.2 Hz, 2H, CH2-cy), 2.60 (s, 3H, CH3), 1.62–1.53 (m, 3H, cy), 1.43–1.33 (m, 3H, cy), 1.09–0.98 (m, 3H, cy), 0.70–0.59 (m, 2H, cy). 13C NMR (101 MHz, CDCl3) δ/ppm = 171.3 (COOH), 159.0 (C-4’), 137.8 (C-2), 134.1 (C-5), 131.0 (C-2’, C-6’), 125.9 (C-1’), 113.9 (C-3’, C-5’), 111.0 (C-3), 110.2 (C-4), 55.3 (OCH3), 50.2 (CH2-cy), 38.9 (cy), 30.5 (cy), 26.2 (cy), 25.8 (cy), 12.3 (CH3). IR (ATR) V~max/cm−1=3027, 3002, 2970, 2925, 2849, 1738, 1652, 1569, 1535, 1494, 1435, 1364, 1266, 1247, 1228, 1203, 840, 778. HRMS (ESI): calculated for C20H24NO3 (M-H)- 326.17617; found 326.17633. Purity (HPLC): 93% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 84\n\nFollowing general procedure C, ethyl acetoacetate (208 µL, 1.65 mmol, 1.1 eq.) in dry THF (5.0 mL), NaH (90.0 mg, 2.25 mmol, 1.5 eq.) and a solution of 2-chloro-1-(2,4-difluorophenyl)ethan-1-one (286 mg, 1.50 mmol, 1.0 eq.) and KI (249 mg, 1.50 mmol, 1.0 eq.) in dry THF (3.0 mL) were used. Then the residue was dissolved in acetic acid (5.0 mL) and cyclohexanemethanamine (390 µL, 3.00 mmol, 2.0 eq.) was added. FCC (hexanes/EtOAc 9:1) yielded SGA-62 as yellow solid (424 mg, 1.17 mmol, 78%). Rf = 0.43 (9:1 hexanes/EtOAc). m.p.: 94°C. 1H NMR (500 MHz, CDCl3) δ/ppm = 7.27 (td, J = 8.4, 6.5 Hz, 1H, 6’-H), 6.96–6.85 (m, 2H, 3’-H, 5’-H), 6.53 (s, 1H, 4 hr), 4.26 (q, J = 7.1 Hz, 2H, CH2CH3), 3.60 (d, J = 7.1 Hz, 2H, CH2-cy), 2.58 (s, 3H, CH3), 1.59–1.53 (m, 3H, cy), 1.38–1.30 (m, 6H, cy, CH2CH3), 1.06–0.98 (m, 3H, cy), 0.68–0.58 (m, 2H, cy). 13C NMR (121 MHz, CDCl3) δ/ppm = 165.5 (COOEt), 162.9 (dd, JCF = 250.1, 11.6 Hz, C-4’), 160.2 (dd, JCF = 248.9, 12.0 Hz, C-2’), 137.2 (C-2), 133.5 (dd, JCF = 9.4, 4.1 Hz, C-6’), 126.2 (C-5), 117.6 (dd, JCF = 15.7, 3.9 Hz, C-1’), 112.3 (C-3), 111.6 (dd, JCF = 21.1, 3.7 Hz, C-5’), 111.3 (C-4), 104.20 (t, JCF = 25.8 Hz, C-3’), 59.4 (CH2CH3), 50.6 (d, JCF = 3.0 Hz, CH2-cy), 39.0 (cy), 30.5 (cy), 26.1 (cy), 25.7 (cy), 14.6 (CH2CH3), 12.0 (CH3). IR (ATR) V~max/cm−1=2971, 2929, 2848, 1739, 1698, 1571, 1426, 1371, 1235, 1199, 1067, 851, 834. HRMS (ESI): calculated for C21H26F2NO2 (M+H)+ 362.19261; found 362.19247. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 85\n\nAccording to general procedure D, LiOH (167 mg, 6.61 mmol, 10 eq.) and a solution of SGA-62 (239 mg, 0.661 mmol, 1.0 eq.) in dioxane/H2O (1.3 mL) were used. After 1 hr the reaction was completed and gave SGA-68 as a colorless solid (170 mg, 0.511 mmol, 77%). Rf = 0.29 (6:1 hexanes/EtOAc). m.p.: 168°C. 1H NMR (400 MHz, CDCl3) δ/ppm = 7.33–7.25 (m, 1H, 6’-H, collapses with chloroform), 6.98–6.86 (m, 2H, 3’-H, 5’-H), 6.60 (s, 1H, 4 hr), 3.62 (d, J = 7.1 Hz, 2H, CH2-cy), 2.61 (s, 3H, CH3), 1.65–1.51 (m, 3H, cy), 1.49–1.32 (m, 3H, cy), 1.14–0.94 (m, 3H, cy), 0.72–0.56 (m, 2H, cy). 13C NMR (101 MHz, CDCl3) δ/ppm = 171.0 (COOH), 163.0 (dd, JCF = 250.3, 11.6 Hz, C-4’), 160.3 (dd, JCF = 249.0, 12.0 Hz, C-2’), 138.5 (C-2), 133.6 (dd, JCF = 9.5, 4.0 Hz, C-6’), 126.7 (C-5), 117.5 (dd, JCF = 15.8, 3.8 Hz, C-1’), 112.0 (C-3), 111.7 (dd, JCF = 21.3, 3.8 Hz, C-5’), 111.6 (C-4), 104.3 (t, JCF = 25.9 Hz, C-3’), 50.72 (d, JCF = 3.0 Hz, CH2-cy), 39.0 (cy), 30.6 (cy), 26.2 (cy), 25.7 (cy), 12.2 (CH3). IR (ATR) V~max/cm−1=2970, 2926, 2854, 1739, 1666, 1573, 1450, 1433, 1364, 1265, 1239, 1200, 1140, 778. HRMS (ESI): calculated for C19H20F2NO2 (M-H)- 332.14676; found 332.14697. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 86\n\nFollowing general procedure C, ethyl acetoacetate (123 µL, 0.972 mmol, 1.1 eq.) in dry THF (4.0 mL), NaH (53.0 mg, 1.32 mmol, 1.5 eq.) and a solution of ketone 24 (250 mg, 0.883 mmol, 1.0 eq.) and KI (147 mg, 0.883 mmol, 1.0 eq.) in dry THF (2.0 mL) were used. Then the residue was dissolved in acetic acid (5.0 mL) and cyclohexanemethanamine (230 µL, 1.77 mmol, 2.0 eq.) was added. FCC (hexanes/EtOAc 9:1) yielded ester 25 as colorless solid (345 mg, 0.845 mmol, 95%). Rf = 0.46 (9:1 hexanes/EtOAc). m.p.: 66°C. 1H NMR (100 MHz, CDCl3) δ/ppm = 7.44–7.29 (m, 4H, 3’-H, 4’-H, 5’-H, 6’-H), 6.53 (s, 1H, 4 hr), 4.27 (q, J = 7.1 Hz, 2H, CH2CH3), 3.59 (d, J = 7.1 Hz, 2H, CH2-cy), 2.59 (s, 3H, CH3), 1.59–1.52 (m, 3H, cy), 1.40–1.32 (m, 6H, cy, CH2CH3), 1.06–0.94 (m, 3H, cy), 0.67–0.54 (m, 2H, cy). 13C NMR (101 MHz, CDCl3) δ/ppm = 165.8 (COOEt), 147.4 (C-2’), 137.1 (C-2), 133.4 (C-4’, C-5’ or C-6’), 129.6 (C-4’, C-5’ or C-6’), 127.9 (C-5), 126.9 (C-1’), 126.7 (C-4’, C-5’ or C-6’), 120.5 (q, JCF = 257.4 Hz, OCF3), 120.4 (C-3’), 112.2 (C-3), 111.4 (C-4), 59.5 (CH2CH3), 50.7 (CH2-cy), 39.0 (cy), 30.6 (cy), 26.2 (cy), 25.8 (cy), 14.7 (CH2CH3), 12.1 (CH3). IR (ATR) V~max/cm−1=1934, 1692, 1447, 1422, 1242, 1192, 1155, 1059, 769. HRMS (ESI): calculated for C22H27F3NO3 (M+H)+ 410.19375; found 410.19336. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 87\n\nAccording to general procedure D, LiOH (142 mg, 5.62 mmol, 10 eq.) and a solution of ester 25 (230 mg, 0.562 mmol, 1.0 eq.) in dioxane/H2O (3.0 mL) were used. After 2 hr the reaction was completed and gave SGA-162 as a colorless solid (199 mg, 0.523 mmol, 93%). Rf = 0.11 (9:1 hexanes/EtOAc). m.p.: 170°C. 1H NMR (400 MHz, CDCl3) δ/ppm = 11.13 (s, 1H, COOH), 7.46–7.30 (m, 4H, 3’-H, 4’-H, 5’-H, 6’-H), 6.59 (s, 1H, 4 hr), 3.60 (d, J = 7.1 Hz, 2H, CH2-cy), 2.61 (s, 3H, CH3), 1.61–1.52 (m, 3H, cy), 1.41–1.31 (m, 3H, cy), 1.09–0.96 (m, 3H, cy), 0.67–0.55 (m, 2H, cy). 13C NMR (101 MHz, CDCl3) δ/ppm = 169.9 (COOH), 147.4 (C-2’), 138.3 (C-2), 133.4 (C-4’, C-5’ or C-6’), 129.8 (C-4’, C-5’ or C-6’), 128.3 (C-5), 126.8 (C-4’, C-5’ or C-6’), 126.7 (C-1’), 120.5 (q, JCF = 260.2 Hz, OCF3), 120.4 (C-4’), 112.1 (C-4), 111.2 (C-3), 50.8 (CH2-cy), 38.9 (cy), 30.6 (cy), 26.2 (cy), 25.7 (cy), 12.3 (CH3). IR (ATR) V~max/cm−1=2927, 1642, 1473, 1444, 1249, 1199, 1156, 776, 759. HRMS (ESI): calculated for C20H21F3NO3 (M-H)- 380.14790; found 380.14805. Purity (HPLC):>96% (λ = 210 nm).\n\nChemical structure 88\n\nFollowing general procedure C, ethyl acetoacetate (104 µL, 0.821 mmol, 1.1 eq.) in dry THF (4.0 mL), NaH (44.8 mg, 1.12 mmol, 1.5 eq.) and a solution of ketone 23 (237 mg, 0.746 mmol, 1.0 eq.) and KI (124 mg, 0.746 mmol, 1.0 eq.) in dry THF (2.0 mL) were used. Then the residue was dissolved in acetic acid (5.0 mL) and benzylamine (204 µL, 1.87 mmol, 2.5 eq.) was added. FCC (hexanes/EtOAc 97:3) yielded ethyl 5-(5-bromo-2-(trifluoromethoxy)phenyl)−1-isopropyl-2-methyl-1H-pyrrole-3-carboxylate (26) as colorless oil (107 mg, 0.222 mmol). This product was used without further purification or characterization for the next step. Rf = 0.44 (9:1 hexanes/EtOAc). According to general procedure D, LiOH (55.9 mg, 2.22 mmol, 10 eq.) and a solution of ester 26 (107 mg, 0.222 mmol, 1.0 eq.) in dioxane/H2O (3.0 mL) were used. After 16 hr the reaction was completed and gave SGA-150 as a colorless solid (34.4 mg, 0.0757 mmol, 10% over two steps). Rf = 0.27 (9:1 hexanes/EtOAc). m.p.: 185°C. 1H NMR (400 MHz, CD2Cl2) δ/ppm = 11.12 (s, 1H, COOH), 7.51 (dd, J = 8.8, 2.5 Hz, 1H, 4’-H), 7.39 (d, J = 2.5 Hz, 1H, 6’-H), 7.30–7.18 (m, 4H, 3’-H, Ph), 6.83–6.77 (m, 2H, Ph), 6.70 (s, 1H, 4 hr), 5.00 (s, 2H, CH2), 2.49 (s, 3H, CH3). 13C NMR (121 MHz, CD2Cl2) δ/ppm = 169.9 (COOH), 147.0 (C-2’), 139.6 (C-2), 137.4 (C-1’), 136.3 (C-6’), 133.4 (C-4’), 129.3 (Ph), 128.5 (qPh), 128.0 (Ph), 127.3 (C-5), 126.2 (Ph), 122.8 (C-3’), 120.8 (q, JCF = 258.7 Hz, OCF3), 120.3 (C-5’), 113.1 (C-4), 112.3 (C-3), 48.7 (CH2), 12.2 (CH3). IR (ATR) V~max/cm−1=2925, 2360, 1670, 1249, 1223, 1198, 1171, 733. HRMS (ESI): calculated for C20H1479BrF3NO3 (M-H)- 452.01146; found 452.01168. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 89\n\nFollowing general procedure C, ethyl acetoacetate (87.6 µL, 0.693 mmol, 1.1 eq.) in dry THF (4.0 mL), NaH (37.8 mg, 0.945 mmol, 1.5 eq.) and a solution of ketone 23 (200 mg, 0.630 mmol, 1.0 eq.) and KI (105 mg, 0.630 mmol, 1.0 eq.) in dry THF (2.0 mL) were used. Then the residue was dissolved in acetic acid (5.0 mL) and isopropylamine (108 µL, 1.26 mmol, 2.0 eq.) was added. FCC (hexanes/EtOAc 99:1) yielded ethyl 5-(5-bromo-2-(trifluoromethoxy)phenyl)−1-isopropyl-2-methyl-1H-pyrrole-3-carboxylate (27) as colorless oil (65.9 mg, 0.152 mmol). This product was used without further purification or characterization for the next step. Rf = 0.55 (9:1 hexanes/EtOAc). According to general procedure D, LiOH (38.3 mg, 1.52 mmol, 10 eq.) and a solution of ester 27 (65.9 mg, 0.152 mmol, 1.0 eq.) in dioxane/H2O (3.0 mL) were used. After 18 hr the reaction was completed and gave SGA-153 as a colorless solid (32.4 mg, 0.0798 mmol, 12% over two steps). Rf = 0.11 (9:1 hexanes/EtOAc). m.p.: 192°C. 1H NMR (400 MHz, C3D6O) δ/ppm = 7.75 (dd, J = 8.8, 2.6 Hz, 1H, 4’-H), 7.65 (d, J = 2.6 Hz, 1H, 6’-H), 7.44 (dq, J = 8.8, 1.5 Hz, 1H, 3’-H), 6.47 (s, 1H, 4 hr), 4.27 (p, J = 7.0 Hz, 1H, CH), 2.72 (s, 3H, CH3), 1.45 (d, J = 7.0 Hz, 6H, CH(CH3)2). 13C NMR (101 MHz, C3D6O) δ/ppm = 166.4 (COOH), 147.7 (C-2’), 137.5 (C-2), 137.0 (C-6’), 134.0 (C-4’), 130.5 (C-1’), 126.4 (C-5), 123.7 (q, J = 257.6 Hz, OCF3), 123.5 (C-3’), 120.6 (C-5’), 113.9 (C-3), 113.0 (C-4), 50.2 (CH), 22.0 (CH(CH3)2), 13.0 (CH3). IR (ATR) V~max/cm−1=2936, 2358, 1672, 1248, 1214, 1200, 1166. HRMS (ESI): calculated for C16H1479BrF3NO3 (M-H)- 404.01146; found 404.01164. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 90\n\nFollowing general procedure C, ethyl acetoacetate (87.6 µL, 0.693 mmol, 1.1 eq.) in dry THF (4.0 mL), NaH (37.8 mg, 0.945 mmol, 1.5 eq.) and a solution of ketone 23 (200 mg, 0.630 mmol, 1.0 eq.) and KI (105 mg, 0.630 mmol, 1.0 eq.) in dry THF (2.0 mL) were used. Then the residue was dissolved in acetic acid (5.0 mL) and n-pentylamine (146 µL, 1.26 mmol, 2.0 eq.) was added. FCC (hexanes/EtOAc 99:1) yielded ethyl 5-(5-bromo-2-(trifluoromethoxy)phenyl)−2-methyl-1-pentyl-1H-pyrrole-3-carboxylate (28) as colorless oil (81.5 mg, 0.176 mmol). The product was used without further purification or characterization for the next step. Rf = 0.51 (9:1 hexanes/EtOAc). According to general procedure D, LiOH (44.4 mg, 1.76 mmol, 10 eq.) and a solution of ester 28 (81.5 mg, 0.176 mmol, 1.0 eq.) in dioxane/H2O (3.0 mL) were used. After 18 hr the reaction was completed and gave SGA-149 as a colorless solid (40.5 mg, 0.0933 mmol, 15% over two steps). Rf = 0.06 (9:1 hexanes/EtOAc). m.p.: 121°C. 1H NMR (400 MHz, CDCl3) δ/ppm = 7.57–7.51 (m, 2H, 4’’-H, 6’’-H), 7.24–7.20 (m, 1H, 3’’-H), 6.61 (s, 1H, 4 hr), 3.74–3.68 (m, 2H, 1’-H), 2.61 (s, 3H, CH3), 1.49–1.43 (m, 2H, 2’-H), 1.19–1.06 (m, 4H, 3’-H, 4’-H), 0.80 (t, J = 7.2 Hz, 3H, 5’-H). 13C NMR (101 MHz, CDCl3) δ/ppm = 169.4 (COOH), 146.6 (C-2’’), 138.3 (C-2), 135.9 (C-6’’), 132.8 (C-4’’), 128.7 (C-5’’), 126.1 (C-5), 122.5 (q, J = 279.8 Hz, OCF3), 122.4 (C-3’’), 120.0 (C-1’’), 112.7 (C-4), 111.4 (C-3), 44.7 (C-1’), 30.2 (C-2’), 28.8 (C-3’), 22.1 (C-4’), 13.9 (C-5’), 11.9 (CH3). IR (ATR) V~max/cm−1=2929, 1663, 1471, 1436, 1247, 1212, 1194, 1160, 781. HRMS (ESI): calculated for C18H2079BrF3NO3 (M+H)+ 434.05732; found 434.05765. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 91\n\nFollowing general procedure C, ethyl propionylacetate (99.9 µL, 0.693 mmol, 1.1 eq.) in dry THF (4.0 mL), NaH (37.8 mg, 0.945 mmol, 1.5 eq.) and a solution of ketone 23 (200 mg, 0.630 mmol, 1.0 eq.) and KI (105 mg, 0.630 mmol, 1.0 eq.) in dry THF (2.0 mL) were used. Then the residue was dissolved in acetic acid (5.0 mL) and cyclohexanemethanamine (164 µL, 1.26 mmol, 2.0 eq.) was added. FCC (hexanes/EtOAc 99:1) yielded ethyl 5-(5-bromo-2-(trifluoromethoxy)phenyl)−1-(cyclohexylmethyl)−2-ethyl-1H-pyrrole-3-carboxylate (29) as colorless oil (98.0 mg, 0.195 mmol). This product was used without further purification or characterization for the next step. Rf = 0.58 (9:1 hexanes/EtOAc). According to general procedure D, LiOH (49.2 mg, 1.95 mmol, 10 eq.) and a solution of ester 29 (98.0 mg, 0.195 mmol, 1.0 eq.) in dioxane/H2O (3.0 mL) were used. After 18 hr the reaction was completed and gave SGA-152 as yellow solid (30.8 mg, 0.0649 mmol, 9% over two steps). Rf = 0.24 (9:1 hexanes/EtOAc). m.p.: 152°C. 1H NMR (500 MHz, CDCl3) δ/ppm = 11.35 (s, 1H, COOH), 7.57–7.50 (m, 2H, 4’-H, 6’-H), 7.20 (dd, J = 8.6, 1.4 Hz, 1H, 3’-H), 6.61 (s, 1H, 4 hr), 3.61 (d, J = 7.2 Hz, 2H, CH2-cy), 3.04 (q, J = 7.4 Hz, 2H, CH2CH3), 1.64–1.54 (m, 3H, cy), 1.39–1.31 (m, 3H, cy), 1.23 (t, J = 7.4 Hz, 3H, CH2CH3), 1.08–0.99 (m, 3H, cy), 0.70–0.60 (m, 2H, cy). 13C NMR (121 MHz, CDCl3) δ/ppm = 169.8 (COOH), 146.3 (C-2’), 145.1 (C-2), 135.5 (C-4’ or C-6’), 132.5 (C-4’ or C-6’), 129.1 (C-1’), 126.7 (C-5), 122.3 (C-3’), 120.3 (q, JCF = 259.2 Hz, OCF3), 120.0 (C-5’), 113.2 (C-4), 110.8 (C-3), 50.9 (CH2-cy), 39.6 (cy), 30.7 (cy), 26.2 (cy), 25.8 (cy), 19.2 (CH2CH3), 14.5 (CH2CH3). IR (ATR) V~max/cm−1=2927, 2359, 1659, 1469, 1441, 1250, 1212, 1192, 1172. HRMS (ESI): calculated for C21H2279BrF3NO3 (M-H)- 472.07406; found 472.07418. Purity (HPLC):>96% (λ = 210 nm),>96% (λ = 254 nm).\n\nChemical structure 92\n\nFollowing general procedure C, ethyl benzoylacetate (134 µL, 0.693 mmol, 1.1 eq.) in dry THF (4.0 mL), NaH (37.8 mg, 0.945 mmol, 1.5 eq.) and a solution of ketone 23 (200 mg, 0.630 mmol, 1.0 eq.) and KI (105 mg, 0.630 mmol, 1.0 eq.) in dry THF (2.0 mL) were used. Then the residue was dissolved in acetic acid (5.0 mL) and cyclohexanemethanamine (328 µL, 2.52 mmol, 4.0 eq.) was added. FCC (hexanes/EtOAc 99:1) yielded ethyl 5-(5-bromo-2-(trifluoromethoxy)phenyl)−1-(cyclohexylmethyl)−2-phenyl-1H-pyrrole-3-carboxylate (30) as yellow solid (151 mg, 0.274 mmol). This product was used without further purification or characterization for the next step. Rf = 0.50 (9:1 hexanes/EtOAc). According to general procedure D, LiOH (69.2 mg, 2.74 mmol, 10 eq.) and a solution of ester 30 (151 mg, 0.274 mmol, 1.0 eq.) in dioxane/H2O (3.0 mL) were used. After 18 hr the reaction was completed and gave SGA-154 as yellow solid (91.5 mg, 0.175 mmol, 28% over two steps). Rf = 0.12 (9:1 hexanes/EtOAc). m.p.: 170°C. 1H NMR (400 MHz, CDCl3) δ/ppm = 7.61 (d, J = 2.5 Hz, 1H, 6’-H), 7.55 (dd, J = 8.7, 2.5 Hz, 1H, 4’-H), 7.47–7.41 (m, 3H, Ph), 7.39–7.35 (m, 2H, Ph), 7.23 (dq, J = 8.7, 1.3 Hz, 1H, 3’-H), 6.74 (s, 1H, 4 hr), 3.56 (d, J = 7.4 Hz, 2H, CH2-cy), 1.48–1.42 (m, 3H, cy), 1.11–1.05 (m, 2H, cy), 1.03–0.95 (m, 1H, cy), 0.90–0.82 (m, 3H, cy"
    }
}